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DESENVOLVIMENTO DE HIDROGEIS MAGNÉTICOS MULTIFUNCIONAIS PARAESTRATÉGIAS DE 
ENGENHARIA DE TECIDOS DA INTERFACE TENDAO/OSSO 
Resumo 
 
As limitações das terapias usadas actualmente no restabelecimento completo das funções de um 
tecido após uma lesão, levaram à criação de novas abordagens de Engenharia de Tecidos e ao 
desenvolvimento de biomateriais funcionais capazes de guiar a sua regeneração. Entre essas 
estratégias, a área da Engenharia de Tecidos que aborda o possivel impacto das forças magnéticas 
propõe, a aplicação de forças e elementos magnéticos como ferramentas multifuncionais 
melhoradas para aplicações biomédicas. Na verdade, o uso de sistemas magnéticos inteligentes 
visa o fornecimento de sinais com instruções celulares melhoradas, que podem ser controlados 
remotamente por elementos magnéticos do sistema dando assim resposta aos requisitos exigidos 
pelo tecido para as terapias de regeneração.  
No caso particular das interfaces de tecidos, como a interface tendão-osso, em que os tecidos são 
interdependentes complexos, torna-se fundamental a produção de sistemas versáteis com 
funcionalidades que possam ser remotamente manipuladas sob a actuação de um campo 
magnético externo. 
Assim, o presente estudo propõe o desenvolvimento de um sistema de transporte de células 
responsivo a um campo magnético, que combina uma matriz fotopolimerizável de sulfato de 
condroitina, enriquecida com lisado de plaquetas (PL), capaz de gerar blocos de construção 
ajustáveis, que visam a construção da interface tendão-osso. Este é um sistema versátil que 
apresenta várias funcionalidades, combinando a modulação das propriedades intrínsecas de um 
hidrogel com um reservatório de células e libertação de factores de crescimento [1].  
De modo a proporcionar uma capacidade de resposta magnética e permitir que o sistema possa 
ser controlado remotamente ou manipulado ex vivo, foram produzidas nanopartículas magnéticas 
(MNPs), revestidas com met-CS (met-CS MNPs), possibilitando a sua ligação com o hidrogel. 
Assim, antes da sua incorporação na matriz do hidrogel de met-CS enriquecida com PL, as Met-
CS MNPs foram produzidas e caracterizadas em termos morfológicos, físico-químicos e 
magnéticos. O impacto da actuação do campo magnético externo nas propriedades intrínsecas do 
sistema foi também avaliado, revelando que este modula o swelling, a degradação e a libertação 
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dos factores de crescimentos naturalmente disponíveis na matriz do hidrogel enriquecida com PL. 
Para além disso, considerando a aplicação do sistema na interface tendão-osso, que é uma zona 
naturalmente predisposta à lesão e que requer não só uma distribuição espacial das diferentes 
populações celulares, mas também um ambiente temporal e espacial estável que possibilite o 
estabelecimento das interacções célula-célula e entre a célula e o seu ambiente, os hidrogéis 
produzidos foram cultivados quer com pre-osteoblastos diferenciados de células estaminais 
derivadas do tecido adiposo (pre-Ost), quer com células de tendão humanas (hTCs). Assim, os 
constructs 3D constituídos apenas por uma unidade (osso ou tendão), ou compostos por duas 
unidades interconectadas (unidades de osso e tendão) foram unidos e cultivados durante 21 dias 
sob estimulação de campo magnético. Posteriormente, procedeu-se à sua caracterização em 
termos de actividade metabólica, proliferação, e expressão proteica dos genes associados ao osso-
tendão. 
Os resultados obtidos confirmaram que tanto as células hTCs como as pre-Ost cultivadas nos 
hidrogéis desenvolvidos no âmbito deste projecto, são capazes de proliferar, colonizar e expressar 
os marcadores associados ao tendão e ao osso, respectivamente, e que MF parece ter um impacto 
na morfologia e produção matriz extracelular que de alguma forma mimetiza os sistemas 
muscoesqueléticos como tendão e osso, efeito esse que é melhorado nos sistemas de co-cultura. 
Em suma, o presente trabalho demostra que os hidrogéis responsivos ao campo magnético 
apresentam propriedades multifuncionais, que podem ser moduladas externamente através de 
estimulação MF. Para além disso, o sistema proposto apresenta ainda potencial para diferentes 
tipos de células e consequentemente diferentes aplicações na área de engenharia de tecidos, 
tendo demonstrado um especial interesse para interfaces de tecido, nomeadamente para a 
interface tendão-osso. 
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Multifunctional Magnetic- Responsive Hydrogels to Engineer Tendon-to-Bone 
Interface 
Abstract 
Magnetic tissue engineering is an innovative approach, in the field of tissue engineering that 
envisions the use of magnetic elements to develop multifunctional systems that can enable remote 
in vitro and/or ex vivo manipulation, as means to address the demanding requirements to achieve  
the successful regeneration of tissues.  This is particularly important for bioengineering complex 
tissues and/or tissue interfaces that must use versatile systems, in order to fulfill diverse requisites 
and enable various functionalities simultaneously. For example, tendon-to-bone interfaces are very 
prone to injury situations that are not completely solved with currently available techniques. 
However, engineering these tissues interface and requires the development of systems that can 
accommodate a proper spatial distribution of different cell populations and provide them an 
appropriate mechanical and biochemical environment. 
Photocrosslinkable natural based hydrogel matrices have received great interest for tissue 
engineering strategies, especially because they provide versatile systems that can be tailored to 
diverse applications. The incorporation of magnetic nanoparticles (MNPs) into these systems might 
enable additional advantages, such as the possibility of being remotely controlled and/or further 
manipulated both in vitro and ex vivo, throught the application of controlled magnetic stimulus. 
Therefore, this work reports on the development of a photocrosslinkable magnetic responsive 
hydrogel made of a methacrylated chondroitin sulfate (met-CS)-based matrix enriched with platelet 
lysate (PL), envisioning the generation of tunable hydrogel building blocks to engineer tissue 
interface such as tendon-to-bone. To provide magnetic responsiveness, magnetic nanoparticles 
(MNPs) coated with met-CS (met-CS MNPs) were produced to enable their linkage to the hydrogel 
matrix.  
For that met- CS MNPs were produced and characterized physically, morphologically and 
physicochemically characterized aiming a further incorporation into met-CS hydrogel matrices 
enriched with PL. The impact of the actuation of an external magnetic in the field into the intrinsic 
properties of the system was assessed, revealing that through the use of this mechanical stimuli it 
is possible to modulate the swelling, degradation and release of growth factors naturally present  
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PL. Moreover the potential use of this versatile hydrogel in tendon-to-bone and the possible impact 
of EMF was assessed in in hydrogels units laden with either pre-osteoblasts differentiated from 
human adipose derived stem cells (pre-Ost) or human tendon derived cells (hTDCs), cultured in 
single units or in co-cultures. The obtained results confirmed that both hTDCs and pre-Ost cells are 
able to proliferate, colonize and express tendon and bone related markers in the developed 
hydrogels. Moreover, EMF seems to impact cell morphology and synthesize a tendon- and bone- 
like ECM, being this effect highlighted in co-culture systems. Together, these results suggest that 
developed hydrogel represents a potential cell laden system for tissues interface engineering in 
which the properties can be externally modulated through EMF stimulation  
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Figure 3.18: Collagen I immunolocation in pre-Ost laden in met-CS200 MAGPL hydrogels, cultured 
for 7 and 21 d under EMF or static culture (non-EMF). 
Figure 3.19: Osteopontin immunolocation in pre-Ost laden in met-CS200 MAGPL hydrogels, cultured 
for 7 and 21 d under EMF or static culture. 
Figure 3.20: Collagen I immunolocation in co-culture met-CS200 MAGPL hydrogels, cultured for 21 
day A) static culture or B) under EMF. 
Figure 3.21: Tenascin-C immunolocation in co-culture met-CS200 MAGPL hydrogels, cultured for 21 
d under EMF or static culture. 
Figure 3.22: Osteopontin immunolocation in co-culture met-CS200 MAGPL hydrogels, cultured for 
21 d under EMF or static culture. 
Figure 3.23: Expression of tendon and bone genes in the single units after 7, 14 and 21 days by 
RT- PCR. 
Figure 3.24: Expression of tendon and bone genes in the co-culture system after 7,14 and 21 days 
by RT-PCR. 
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MAGNETIC-RESPONSIVE MATERIALS FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE 
 
 
Abstract 
 
Novel tissue engineering approaches are emerging to meet regenerative medicine demands and challenges 
towards successful therapies to completely restore the function in damaged or degenerated tissues. Among 
them, magnetic tissue engineering envisions the development of complex systems in which magnetic 
elements are exploited as remotely controlled multidimensional tools with potential for diagnostic and 
therapeutic actions.  
This chapter provides an overview of the latest developments on the design and assessment of magnetic 
tissue engineering strategies with particular emphasis on smart magnetic materials and its relevance for 
tissue regeneration. Special attention will be given to the fabrication of sophisticated systems from nano to 
macro scale, and to the role of magnetic smart materials for providing alternative approaches to address 
the demanding tissue requirements and meet successful alternative strategies for regenerative medicine. 
The cellular response to the presence of magnetic elements will be also considered in this chapter, including 
internalization and clearance mechanisms as well as the relevance of magnetic stimulation for cell 
proliferation and differentiation among other biological processes.  
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1. INTRODUCTION 
1.1  Magnetic Forces in Living Systems  
All living organisms are daily exposed to the influence of external forces characterized by distinct physical 
parameters, including the stimuli provided by magnetic fields. Magnetic forces reveal a fundamental 
influence in processes as different as the seasonal migration of bird and mammal species, or the 
homeostasis and equilibrium of endogenous biological processes.[2] 
Indeed, living organisms, namely the rainbow trout and some species of bacteria, align themselves with 
Earth´s North Pole. In bacteria, the biological response is due to the presence of magnetosome, an 
organelle that contains magnetite, the principal element involved in their magnetic responsive capacity, 
which orients magnetotactic bacteria towards the direction of the magnetic field.[3],[4] 
The discovery of these intriguing features in living organisms renewed interest in the relevance of magnetic 
forces application to the human body and the potential action of magnetic properties in diagnostics and 
therapies. Biomedical applications of magnetic elements, for instance, as contrast agents in magnetic 
resonance imaging[5] have been explored and established as successful screening platforms while others 
as biosensors are steadly arising into the clinical scenario.[5], [6] 
Considering the potential effect of magnetic forces in biological systems and promising outcomes in the 
diagnosis and therapeutic fields, magnetic stimulation may significantly influence wound healing and tissue 
regeneration. Magnetic forces have been described to act at the cellular level, enhancing the rate of survival 
of cells, including H9C2 cells after ischemia,[7] and influencing the differentiation process towards the 
osteogenic and chondrogenic phenotype of adipose derived stem cells.[8] Furthermore, cellular mechano-
sensing and mechano-stimulation provided by external magnetic forces may play an important role in 
appropriate tissue formation by inducing intracellular processes via signaling pathways.[9] The exposure 
time and the intensity of the applied magnetic field also impacts different cell types including bone 
mesenchymal stem cells[10] and hippocampal neurons[11] in terms of cell processes as proliferation and 
differentiation.[10, 11] 
Mechanical forces can be therapeutically administrated to assist the regeneration of musculoskeletal 
tissues. Pulsed electromagnetic field (PEMF) therapy is an FDA-approved treatment for orthopedics 
commonly utilized to encourage bridging of delayed or non-union bone defects since 1979.[12] 
1.2  Magnetic Force Tissue Engineering 
The capacity to successfully mimic a complex tissue, providing the essential microenvironment to the cells 
and stimulate the formation of functional tissues in order to ultimately promote the regeneration of damaged 
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or degenerated tissues remains one of the biggest challenges in the tissue engineering regenerative 
medicine field.[13] This challenge has inspired the development of stimuli-sensitive systems, also known as 
“smart” materials that sensibly and reversibly respond to a stimulus and, to some extent, have the capacity 
of adaptation. The stimulus can be achieved by external regulation using magnetic and electromagnetic 
forces, alterations in the temperature, light or through internal regulation by local changes in pH, ionic 
strength or by specific interactions.[14],[15], [16],[17],[18],[19] As a response, the material can change its 
shape, alter surface characteristics or solubility, go through molecular assembly or into a sol-to-gel 
transition.[20] If efficiently applied, the stimulus provides essential cues that assist the interaction among 
the biomaterial surface, extracellular matrix and cells, with potential to enhance vital functions such as 
adhesion, proliferation, migration, and tissue differentiation. Moreover, smart materials can be designed 
and fabricated to meet multi-functional parameters and still be precisely controlled (e.g. respond to multiple 
stimuli, in a time-spatial manner).[20] Unlike pH or temperature, the actuation of magnetic forces offers the 
advantage of being externally monitored and triggered over implanted scaffolds, cells or constructs to 
stimulate a therapeutic action, as often as desired, with different intensities during treatment or even under 
a continuous or interrupted manner.[20] Moreover, it is simultaneously, a highly precise and non-invasive 
tracking, guiding and monitoring system that can be easily and fastly turned on or off.  
The increasing number of studies with reference to novel applications of magnetic nanoparticles and 
magnetic stimulation gave risen to a new concept of magnetic force-based tissue engineering (magTE) 
proposed by Ito and colleagues in 2004.[21] Since then, great possibilities were offered to TERM strategies 
from cell selection, monitoring and guidance to cellular assemble into 3D structures or towards the 
development of multi-functional and sophisticated 3D architectures to recapitulate native tissues.[21] 
1.3 Magnetic Particles for TERM Applications 
The responsiveness of materials to magnetic forces is based on the fact that certain magnetic elements 
such as iron, cobalt, nickel and manganese within the material attract or repel each other through the 
movement of charged particles. These elements are frequently found in nature as particulate matter in 
volcanic eruptions, in minerals or as part of cell metabolism in the form of ferritin in the heart, spleen and 
liver in humans.[2],[22] Magnetic materials can be found with different dimensions and shapes as tubes, 
rods or spherical components like magnetic nanoparticles (MNPs) that can be further arranged into higher 
complex systems to form micro- and macro-scale structures of increased complexity. The magnetic 
nanoparticles (MNPs) in particular, are quite versatile and combine unique physicochemical properties with 
a large surface area that can be properly modified to bond to biological agents. MPs studies based on cobalt, 
nickel and manganese suggest some level of cytotoxicity and susceptibility to oxidation which may limit their 
use for biomedical applications.[23] Alternatively, iron MPs have been more investigated for biomedical 
Chapter I: General Introduction 
  
6
 
purposes because of their lower cytotoxicity in comparison to other MPs, including cell tracking, cell sorting, 
drug release or gene therapy, suggesting a relevant role in theranostic strategies.[24],[25] 
1.3.1  Properties of Magnetic Particles 
The magnetic properties of MPs are commonly defined by magnetization, coercivity and saturation 
magnetization. The frequency of the external magnetic field applied to a solution of MPs is often low; around 
few kHz or less, and mostly influences MPs rotation movement which will affect MPs magnetization 
alignment, and afterwards influence MPs to move along the direction of the magnetic forces. Saturation 
magnetization is the maximum magnetization value of a nanoparticle under a high magnetic field while 
coercivity refers to the ability of a particular material to have magnetization without the application of a 
magnetic field. Zero coercivity, that is no residual magnetization, is essential in magnetic platforms for 
biomedical applications as well as appropriate and uniform MPs dimensions in combination with high 
magnetization values and colloidal stability.[25]  
Moreover, MPs have the intrinsic capacity to be heated, and thus increase the temperature in the nearby 
environment by the actuation of an alternating magnetic field (AMF). Under the actuation of an AMF the 
magnetic moments of the MPs rotate, and heat is released when the MPs relax back to their original 
magnetic orientation.[25] This property of MPs has been explored in hyperthermia cancer treatments and 
can be further combined with thermo-responsive materials for bioagent delivery to be released upon 
magnetic stimulation.[1] 
1.3.2  Superparamagnetic Iron Oxide Nanoparticles (SPIONs) 
One particularly interesting subset of MNPs are superparamagnetic iron oxide nanoparticles (SPIONs), once 
they possess robust magnetic nature under the influence of an external magnetic field. SPIONs rotate to 
align themselves along the field and do not retain any reminiscent magnetism, with zero coercivity after 
removal of the magnetic force.  The superparamagnetic behavior of MNPs is achieved when the particles 
dimensions are below the critical size (Rc). Below the Rc threshold it is energetically favorable for the 
magnetic particle exist with a single domain which happens typically in the range of a few nanometers.[26]  
SPIONs core normally consists of ferromagnetic magnetite (Fe3O4) and magnetite (Fe2O3), but sometimes 
results from combinations with other elements like copper, cobalt, and nickel. The low-toxic nature of 
SPIONs and the superparamagnetic features highlight their promising outcomes for biomedical and tissue 
engineering applications.[27] Like other types of MNPs, SPIONs can be remotely controlled and 
concentrated in a target in vivo location by the application of magnetic forces. However, the most 
distinguishable characteristic of SPIONs is the capability to be magnetized only when a magnetic field is 
applied, presenting the possibility of being “turned off” upon removal of the magnetic field. This singularity 
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of SPIONs avoids superparamagnetic particles to clog and potentially eliminates the threat of embolism 
within small capillaries as the risk of agglomeration is negligible.  
1.3.3 Coating and Functionalization of MPS 
Under physiological conditions (pH=7.4 and ionic strength= 150mM), iron oxide nanoparticles tend to 
aggregate once the stability of magnetic particles depends on a balance between attractive and repulsive 
forces.[25] Furthermore, MPs properties as effective surface charge, degree of dispersion, degree of 
aggregation or hydrodynamic size are directly influenced by the MNPs suspending media.[25] In order to 
overcome the low stability in physiological conditions, protect MNPs against aggregation and promote better 
biocompatibility and improved functionality, the surface of MNPs can be coated with materials as, for 
instance, polyethylene glycol (PEG),[25] dextran, chitosan, hyaluronic acid, or chondroitin sulfate.[28] MPs 
coated with hydrophilic polymers (e.g. PEG, dextran) have shown higher half-life in biological fluids in 
comparison with uncoated magnetic particles.[25] A hydrophilic coating results in fewer interactions with 
the components of blood, because they sterically hinder the interactions between the MPs and the 
opsonization proteins through a shielding process, and also due to the phenomenon of solvation resultant 
from the interaction with water molecules. Consequently these MPs have a slower clearance rate and 
evidence higher life span in the host.[25] Particles mainly constituted of hydrophobic domains at the surface 
are rapidly and efficiently coated with plasma components, and consequently more rapidly removed from 
blood circulation by the mononuclear phagocyte system (also called reticuloendothelial system or 
macrophage system).[29],[30] If desired, protection from interactions with blood elements can be assured 
using amphiphilic copolymers that spread in contact with aqueous solutions leading to a sterically diminution 
of probability of contact with these elements.[31] 
Lipid-like coatings of the magnetic core forming liposomes and lipid NPs are a potential alternative to 
polymer coatings due to their versatile and tailorable structure and biocompatibility, being considerably 
explored in drug delivery mainly because of their intrinsic capacity to accommodate and release a wide 
range of therapeutic agents.[32]  
Inorganic metals like gold are also used for the MNPs coating but the process itself is difficult and 
demanding.[33] Coatings with nonmetallic materials as graphite, or silica have also been strategically 
applied to provide chemical stability against oxidation.[34],[35] The type of coating and its conformation will 
influence not only the degree of aggregation of MPs but also the surface charge, hydrodynamic size and will 
play an important role regarding MNPs biological fate. 
The functionalization via coating will tune the response of the particle itself with biological elements and will 
determine the surface properties of the MNP.[36] The nature and the thickness of the coating influence the 
magnetic properties and act as a protective barrier against the interaction and eventual collision among 
MNPs, keeping them apart from one another, thus leading to stable magnetic formulations.[25] The surface 
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coating, independently of the type of materials used, can be further functionalized with a vast range of 
complex and highly efficient molecules, including antibodies,[37] lectins, proteins,[38], hormones,[39] 
charged molecules and some low molecular weight ligands.[40] These molecules allow to target, monitor 
and track in real time a specific process with precise recognition from the cellular level (surface molecules 
and intracellular organelles of a desired cell type) to the macro scale of tissues and organs.  
The type of coating and its conformation will influence not only the degree of aggregation of MPs but also 
the surface charge, hydrodynamic size and will play an important role regarding MNPs biological fate.  
The surface charge of a coated magnetic particle is influenced by electrolytic solutions like blood, which will 
influence MPs affinity for adsorption of ions, proteins and natural organic materials. The charge and the 
type of coating have a relevant effect on the type of proteins adsorbed, on the strength of the interaction 
and on the hydrodynamic diameter of MNPs.[41] 
The influence of surface charge in the rate of internalization has been studied with dimercaptosuccinic acid 
(DMSA) coated MNPs (17.3 ± 4.8 nm, negative surface charge), chitosan coated MNPs (16.5 ± 6.1 nm, 
positive surface charge) and agglomerates of both (DMSA/Ch, 85.7 ± 72.9 nm, highest positive surface 
charge) cultured with oral squamous carcinoma cell KB at physiological conditions. DMSA MNPs showed 
the lowest cellular uptake while the agglomerates of DMSA/Ch exhibited the highest cellular uptake.[42]  
 
1.3.4 Dimension oriented Applications of Magnetic Particles 
The magnetic properties of the MPs can be tailored by controlling the size of MPs. As referred before the 
MNPs dimensions will impact on the responsiveness to the magnetic field through the saturation of 
magnetization that was shown to diminish with the decrease of the magnetic particle size.[43] Thus, the 
choice for the optimal size is fundamental to target a desired function. Smaller particles have a larger surface 
area to volume ratio and higher magnetization density in comparison with magnetic microparticles. Due to 
their small size, nanoparticles are normally selected for cell recognition or specific capture of a biological 
entity, diagnosis or even for the treatment of diverse diseases like cancer, taking advantage of their intrinsic 
capacity to extravasate through the endothelium in inflammation sites, epithelium, and tumors in 
combination with their high stability in solution.[44] Moreover, the release of a molecule can also be tuned 
by controlling the size of the MPs.[45]  
Sub-micron MPs can theoretically generate heat and thus induce an increase in the temperature in the 
surroundings when an alternating magnetic field (AMF) is applied.[25] Magnetic hyperthermia has been 
used in cancer treatment since tumor cells are hypersensitive to higher temperatures in comparison with 
healthy cells. The intensity of generated heat can be tuned through the manipulation of magnetic features 
like the size of MPs or by the manipulation of the actuation parameters of the external magnetic field.[46] 
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Moreover, internalized magnetic particles were described to kill cancer cells simply by exposure of the cells 
to an AMF without perceptible temperature rise, which led to the new terminology “Magnetically mediated 
energy delivery”.[47] 
Moreover, SPIONs offer the possibility to be conjugated with MRI techniques to localize the tumor and 
subsequently induce a hyperthermia treatment.[48] For example in a work developed by Jain and colleagues 
MRI was combined with liposomal iron oxide nanoparticles to treat glioblastoma multiform, a primary 
malignant tumor of the brain.[49] This nanoparticulate system was also found to be promising as drug 
delivery carriers across the blood-brain barrier (BBB), which has been a severe limitation of currently 
available treatments. MPs have been produced with different physico-chemistry properties and coating 
shells to improve their biocompatibility, reduce aggregation and to acquire specific functionalities which are 
envisioned to influence and direct the final application of MPs. In this sense, MPs have been explored as 
referred before for hyperthermia and diagnosis such as contrast agents in magnetic resonance imaging [5], 
and more recently for bio-agent delivery, tissue engineering and biosensing (Figure 20.1). [25],[43],[50] 
Also the combination of multiple functionalities in a single MP can lead to the development of “theranostics” 
to address diagnosis and therapy simultaneously, which represents an important route of MP technology 
toward clinical therapies (Figure 1.1). For biosensing applications in particular, MNPs have been used to 
enhance the sensitivity and the stability of biosensors for the detection of several biomolecules. An example 
is the work developed by Li and colleagues in which a magnetoresistive biosensor with nanoparticles 
(approximately 12.8 nm) was used as a detection platform for rapid quantification of biomolecules such as 
interleukin-6 from body fluids.[51] 
 
Figure 1.1: Magnetic Particles for biomedical applications. The surface coating and functionalization of MPs 
will ensure biocompatibility, prevent aggregation and provide cues for the isolation, sorting and tracking of 
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cells or biomolecule through bonding of highly specific antibodies or proteins, for cell and drug delivery and 
cell imaging. These properties assist the use of MPs for promising biosensor technologies, tissue 
engineering strategies and as effective diagnostic tools. Furthermore, the ability of MPs to generate heat 
has also motivated their use in hyperthermia studies aiming at cancer treatments or at controlling the 
release profile of incorporated drugs or growth factors. Another interesting feature of MPs is that these 
properties can be combined into multifunctional MPs with potential to synergistically act with diagnosis and 
therapeutic actions and thus as complex theranostic instruments for the clinical field. 
1.4 Cell Response to Magnetic Elements 
1.4.1  Cytotoxicity, Internalization and Clearance 
There are several parameters of considerable importance that can influence the biocompatibility of the 
magnetic particles, including the type of raw biomaterial, dimensions, shape, concentration, route and local 
of administration.[52],[23]  
Not only is biosafety assurance a key parameter for clinical applications but it is also crucial to understand 
the bio-transformation of the MPs within the body and the mechanisms that determine their course of action 
and elimination. 
The interaction of MPs with the biological systems, more specifically how the particles react with cells, 
proteins, hormones, and plasma constituents is important for predicting the biodistribution of by-products 
resultant from particles biodegradation and bioresorption.[29] MNPs with iron cores have been described 
to be more biocompatible and non-cytotoxic than cobalt, nickel or manganese MNPs. In a study by Karlsson 
and colleagues the toxicity of metal oxides of nano- (<100 nm) and micro- particles (<5 µm) of Fe2O3, 
Fe3O4, TiO2 and CuO was evaluated using a human alveolar type II-like epithelial cell line.[23] The iron 
oxides particles showed very low cytotoxicity levels in comparison to CuO and TiO2 particles for 
concentrations up to 100 µg/ml, without significant differences among particles of different dimensions.[23] 
Iron oxide MNPs uptake by different cells showed no evidence of a pejorative cellular response. Furthermore, 
Ferumoxides (Ferridex®)[53] and Ferucarbotran (Resovist®),[54] which are also iron oxide MNPs, have 
been FDA approved for clinical applications in MRI imaging. This data suggests the applicability of these 
particles for tissue engineering and regenerative medicine approaches.[14],[55],[56] However, each and 
newly developed MP presents a unique combination of features and properties, which implies that MPs 
should be individually considered and evaluated regarding their functionality and biocompatibility. Besides 
particle dimensions, the physicochemical properties may also influence the potential outcomes of using 
MPs in living entities.[29] Although MPs are expected to bring great benefits into therapeutics and 
biomedicine, the in vivo response needs to be assessed so that limitations and drawbacks can be safely 
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overcome. Magnetic targeting of MPs specifically to a tissue/organ can rise the local iron concentration 
disturbing iron homeostasis. Additionally, because of the large surface area to mass ratio, MNPs may diffuse 
across biological membranes and tissues barriers which could potentially induce cytotoxicity (DNA damage, 
oxidative stress) in a concentration dependent manner.[29] Furthermore, free iron released upon MPs 
degradation can produce reactive radicals and consequently may cause cellular deterioration, death or 
carcinogenesis.[57] The application of an AMF in combination with MPs can also impact on the cellular 
homeostasis and increase the production of reactive oxygen species (ROS).[58]  
Despite these possible risks, it is generally accepted that in a concentration dependent manner, iron oxides 
are non-toxic to cells since they can be degraded via endogenous iron metabolism and metabolized into its 
basic elements.[59] For instance, Pisanic and colleagues have demonstrated that SPIONs coated with 
dimercaptosuccinic acid have elicited a dose-dependent cytotoxicity ([Fe] = 0.15-15 mM) when cultured 
with a neuronal cell line. They found that the particles diminished the ability of the cells to either survive or 
demonstrate normal biological responses and morphologies.[60] In another work, Jeng and colleagues have 
shown that high concentrations of metal oxide particles ([Fe] ≈ 2.5 mM) have a statistically significant 
negative effect upon mitochondrial function in Neuro-2A (mouse neuroblastoma, CCL-131, ATCC) cell lines. 
[61] 
Iron is a metal but also an essential and highly conserved nutrient involved in several systemic and cellular 
functions. Macrophages and hepatocytes play an important role for the systemic storage of iron that is not 
needed for immediate use. Iron is stored in liver and available in blood circulation where it is required for 
the production of hemoglobin in hema-groups of red blood cells.[62] 
Human iron metabolism refers to a balance between iron uptake, storage and excretion/loss, which is 
challenged by iron homeostasis. Iron in circulation bounds to transferrin [63], an abundant plasma protein 
that binds to iron atoms with extremely high affinity.[64] At this stage iron can be taken up by tissues with 
transferrin receptors.[65] However if iron is not bounded (free iron form), it can lead to several damages in 
the organism. Thus, iron homeostasis aims to avoid the potential detrimental effects of free-iron without 
losing its benefits. To maintain the balance, iron absorption, storage and excretion are meticulously 
controlled, being a small fraction of iron intake absorbed and the remaining excess eliminated by cellular 
excretion through skin, urine or blood loss.[64] 
MPs can be recycled or cleared in a relatively short-term through regular excretion routes (Figure 1.2). The 
MP coating undergo progressive degradation and predominant renal elimination while iron in its elementar 
form can be eliminated, predominantly via the faeces.[66] Their clearance from the body has been described 
to occur through a model of lysosomal metabolism of iron oxide nanoparticles and mechanisms of 
nanoparticle degradation. [67],[68],[69]   
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Figure 1.2: Clearance and elimination routes of MPs. Independently of the administration route it is likely 
that MP will ultimately reach the vascular system. Depending on the surface properties of MNPs like charge, 
size, coating or functionalization, the MPs may undergo adsorption or opsonization by serum proteins that 
will further mediate macrophage intervention and MNP phagocytosis and lysosomal elimination. The MPs 
can be cleared from the organism through different routes; mainly by kidney, liver or gastro-intestinal 
excretion. The kidney rapidly removes 5–6 nm particles from the vascular compartment via renal filtration 
and urinary excretion. When kidney excretion is not possible, the hepatobiliary system becomes the primary 
route of excretion for MPs before the release of MPs into the gastrointestinal tract for elimination through 
faeces. 
 
Another important aspect to be considered in MP-body dynamics is the complex interactions between cells 
and MPs. Considering the size, the physicochemical characteristics and the biological entities that decorate 
the MPs, MPs can be effectively internalized by cells. This interplay of cues results in different mechanisms 
of cellular uptake and consequently intracellular sorting toward different compartments.[70] Studies of co-
incubation of cells and MPs evidenced that the particles are commonly internalized through spontaneous 
endocytosis pathways or by phagocytosis.[71]   
As the cellular membrane is negatively charged, positively charged particles are more efficiently and rapidly 
endocytosed. Although the rate and the type of endocytosis also depend on the type of cell, MNP dimensions 
influence the rate of internalization and the internalization route.[72] In fact, all particles with size ranging 
from 10 nm to 500 nm and limited up to 5 µm can be internalized through different pathways depending 
on the cell type and other properties but the larger particles of approximately 5 µm are the most likely to be 
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engulfed via micropinocytosis.[73] MNPs up to 2 nm can pass through passive diffusion by cell membranes, 
capillaries, and even through the blood-brain barrier, which may interfere with cell metabolism and lead to 
several damages.[74]  
The shape of MPs also influences the biocompatibility and bio-distribution. Rod-based NPs have shown an 
increased cellular uptake in comparison with spherical NPs for sizes over 100nm.[43] This outcome may 
be associated to the position of rod NPs that evidence different length and width dimensions, to present 
themselves to the cell. However, when the spherical MNPs have sizes up to 100 nm, cell uptake behavior 
is just the opposite.[75] Thus, the versatility of MPs in terms of particle design and consequently their 
intrinsic characteristics as well as MPs interaction and functionality with the environment and biological 
entities, should be carefully considered and investigated to address a particular need and TERM application. 
1.4.2  Mechanosensing & Mechanotransduction Pathways 
Interactions between the cell and its microenvironment are crucial for triggering endogenous mechanisms 
fundamental for morphogenesis, tissue homeostasis, remodeling and pathogenesis. Magnetic fields per se 
influence the activation of mechanotransduction signaling pathways, stem cell differentiation and the 
presence of anti- and pro-apoptotic molecules. Cells are endowed with the capability of sensing these 
external mechanical stimuli and translating them into a biochemical response, a process termed as 
mechanotransduction.[76]  
Although the mechanisms underlying the therapeutic action of pulsed electromagnetic field  (PEMF), that 
can be viewed as the combination of an electric field (stationary charges) and a magnetic field (moving 
charges), remain to be entirely understood, it is increasingly evident that cells are able to perceive 
electromagnetic fields as any other source of environmental stress and react accordingly. This is mediated 
via the mechanotransduction signaling pathway MAPK, a pathway classically activated upon osmotic shock, 
radiation or any other kind of environmental stress. It contains 3 branches, ERK, p38 and JNK and the 
active form of p38 (phosphorylated) and ERK 1/2-cbfa1 signaling has been proposed to accelerate 
osteogenesis.[7],[77] This may actually help understanding why PEMF is successfully at encouraging bone 
regeneration. Besides stem cell commitment, magnetic fields also influence the expression of stress proteins 
and influence the expression of pro-survival and apoptotic genes. In example, pre-stimulation of rat heart-
derived cells with a 60 Hz magnetic field enhance the levels of the heat shock protein 25 (Hsp25), increase 
the levels of Bcl-2, an anti-apoptotic protein, and reduce activity of apoptotic caspase 3, 8 and 9.[78] 
Magnetic fields in combination with magnetic responsive biomaterials present further advantages. This is 
supported by a number of recent studies addressing the potential of magnetically actuated biomaterials in 
angiogenesis and bone TE. Endothelial cells cultured in magnetite-impregnated alginate scaffolds and 
alginate scaffolds (control) formed tube-like structures after 7 days of magnetic stimulation at 40 Hz and 
10-15 Oe. Although both materials supported the formation of such primordial blood vessels, the number 
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of lumens was significantly higher in the magnetically actuated alginate suggesting a synergistic effect 
between the magnetic field and the magnetic biomaterial.[79] Cardiac cells cultured in a similar material 
caused significant activation of AKT, a promoter of cell hypertrophy and survival, but also troponin-T, a pro-
survival contractile protein, after 6 days of stimulation at 5 Hz and 10-15 Gauss.[79] Only cells from the 
magnetically actuated alginate presented these patterns of protein expression. As referred above, 
magnetically actuated materials have been showing great promise in bone TE. Magnetic polylactic acid and 
hydroxyapatite scaffolds implanted in lumbar transverse defects of New Zealand white rabbits have 
evidenced a positive effect in bone regeneration upon the establishment of static magnetic field.[80] Twenty 
days post implantation osteoblasts and the bone protein osteocalcin were found in greater abundance in 
tissue sections from the magnetically actuated scaffold group, resulting overall in better organized collagen 
fibers and more newly formed bone at day 30.[81] Magnetic actuation concomitantly combined with 
magnetic responsive have been successfully utilized to accelerate osteogenesis, promote the formation of 
new blood vessels and encouraging the presence of pro-survival molecules or activation of pro-survival 
signaling pathways.  
Thus, it is critical to continue exploring the mechanisms behind cell magnetic stimulation to fully understand 
and characterize the actuation of magnetic forces in each tissue or organ, and how these forces can be 
combined with smart magnetic materials as a mean to improve TERM strategies.  
1.5 Magnetic Responsive 3D Systems 
Tissue engineering (TE) strategies rely on multiple combinations of cells, scaffolds and bioactive agents, 
some of them with therapeutic action, in order to provide the most suitable environment and promote 
regeneration in detriment of repair. The improvements in TE are intimately associated with the biomaterials 
to assist tissue formation and regeneration.  
TE approaches which provide a bioengineered product that stimulates regeneration while simultaneously 
enabling real-time follow up will be a major advance in clinical therapies. Magnetic smart materials offer 
such new perspectives in TE (Figure 1.3). 
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Figure 1.3: Magnetic smart-materials for tissue engineering applications. A) Iron oxide particles (MPs) can 
be found with different dimensions and shapes as tubes, rods or spherical components. B) These MPs can 
be functionalized via coating in order to have a better biocompatibility and improved functionality with 
biomolecules, including antibodies, lectins, proteins, hormones, charged molecules and some low molecular 
weight ligands. Functionalized/ non-functionalized MPs can be incorporated in a non-magnetic matrix 
originating magnetic responsive systems (C, D, E, F and G); C) Magnetic responsive spheres or capsules 
produced through the dispersion/synthetization of MPs within the polymeric matrix, magnetic particle core 
coated with non-magnetic material or by the fabrication of spheres with a polymeric matrix core coated with 
MPs. D) Magnetic responsive hydrogels where MPs are dispersed/synthetized within the polymeric matrix. 
E) Magnetic scaffolds where MPs can be directly incorporated within the non-magnetic matrix matrix or in 
the cells through cell labeling, if cells are intended to be seeded or cultured on a scaffold prior implantation. 
F) Cell sheets with magnetically pre-labelled cells. G) Magnetoliposomes (MLs) in which MPs can be coated 
with a phospholipid bilayer, embedded in the lipid bilayer or being encapsulated in the internal aqueous 
space of unilamellar vesicles.  These MLs can be further used to produce cell sheets (H). In the case of 
spheres (C), hydrogels (D) and scaffolds (E) in which MPs are dispersed/synthetized within the non-
magnetic matrix, the MPs can be either cross-linked to the matrix or dispersed through the pores. 
 
The most common fabrication procedures for magnetic materials, either as particulate systems, gels, 
scaffolds or others, are based on the incorporation of magnetic particles in a non-magnetic matrix.[29] 
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The non-magnetic matrix complements MPs functionality preventing the aggregation of the MNPs, protecting 
them against oxidation and allowing the bond of functional groups.[25] This matrix will also improve the 
stability of the tissue engineered construct and can assist the inclusion of new physical and biological 
properties, and consequently multifunctional behavior.  
The selection of the non-magnetic matrix with appropriate composition and architectural features is thus a 
critical step envisioning a successful tissue engineered substitute. Distinct materials have been applied for 
the production of these matrices, including natural and synthetic polymers as well as ceramics materials. 
Each type of materials, used alone, blended or combined as composite materials, present specifications 
than can be more advantageous considering the application they are intended to.  
The incorporation of magnetic nanoparticles within 3D architectures constitutes an attractive approach to 
achieve magnetically responsive systems enabling remote control and stimulation of cell laden 
constructs.[76] Diverse templates of smart magnetic materials from spheres, liposomes, gels to 3D 
hierarchical structures have been explored for TERM strategies (Figure 1.3).[28],[82],[83],[84] 
MNPs can be integrated within 3D scaffolds directly or by previous association with (stem) cells (Figure 
1.3E).[85] After incorporation, the application of an external magnetic field may induce scaffold structure 
deformation. The matrix structure and properties will relate to their application and on the fabrication 
methodologies that include bottom-up methods through the assembly of building blocks (Figure 1.4) and 
3D printing technologies.[86] 
 
 
Figure 1.4: Smart Magnetic Hydrogels as building blocks for tissue engineering applications. Hierarchical 
and complex systems can be achieved incorporating magnetic nanoparticles in a 3D porous hydrogel, 
conferring magnetic responsiveness capacity. The application of a magnetic field will potentially promote 
self-assembly of the hydrogels originating complex and well-defined 3D- architectures combined or not with 
encapsulated cells. These constructs can be further implanted and potentially promote cellular mechano-
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stimulation under the actuation of a magnetic field that may influence appropriate tissue formation by 
inducing intracellular processes via signaling pathways. 
1.5.1  Magnetic Systems: Spheres, Capsules and Liposomes 
Magnetic spheres, capsules, and lipid layered vesicles as liposomes and water-in-oil droplets, can be 
produced from combinations of different biomaterials, often polymeric matrices or lipid based materials 
incorporated with MPs (Figure 1.3C,G). 
The  strategies to produce magnetic spheres are the encapsulation of MPs in a biodegradable polymeric 
matrix that usually rely on either i) uniformly disperse MPs within the polymeric matrix; ii) induce the 
formation of a MPs core within the sphere; or iii) the fabrication of spheres with a polymeric matrix core 
coated with MPs (Figure 1.3 C).[87],[88]  
These magnetic spherical-shape structures are envisioned for a wide range of applications including 
controlled delivery, diagnostic MRI, tissue regeneration and cancer therapies mediated by hyperthermia.[5] 
Several biofabrication techniques have been exploited to produce magnetically responsive spheres, being 
the layer-by-layer (LbL) deposition, the most commonly used. LbL consists in the preparation of a multi-
layered film by the sequential deposition of alternating layers of oppositely charged materials, in which MPs 
can be easily integrated between the layers through surface modification.[89]   
Their versatile intrinsic properties enable their use in encapsulation/release systems since they serve as 
protective carriers of pharmaceutical agents, genes, cells and growth factors (GFs) to be delivered at specific 
sites.[1] For effectiveness, the bioactive agent should be released on demand and at tunable rates. In this 
aspect, magnetic responsiveness is fundamental once magnetic forces are very well suited to control the 
rate of drug release and biomolecules in biological systems and because the human body has a great 
acceptability to static and alternating magnetic fields.[90]   
Particularly in drug delivery, magnetic spheres are a useful tool due to their small size that leads to large 
surface/volume ratio, great loading efficiency, high diffusibility, motility and excellent capacity to rapidly 
respond to the stimuli of the surrounding environment.[1],[91],[92] For example under the influence of an 
electromagnetic field (EMF), the release of an anticancer drug, doxorubicin, co-encapsulated with magnetic 
nanoparticles (Fe3O4) in polylactide spheres was prolonged without a burst effect which ensures minimal 
exposure for the healthy cells, and locally increases drug release.[93] Another work [94] reported the 
feasibility of the encapsulation of hybrid chitosan/hyaluronic acid nanoparticles by spray drying into 
microspheres with an aerodynamic diameter of approximately 2.6 µm for lung delivery. The  homogeneously 
distribution of MNPs in this carrier resulted in a dry powder with appropriate aerodynamic properties.[94] 
Magnetic alginate microspheres have also been used in another study to deliver neuron growth factor [1] in 
a control manner assisted by the application of EMF targeting PC12 cells, a cell line derived from a rat 
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pheochromocytoma.[56] The NGF release in combination with the magnetic field was able to promote 
cellular differentiation of these cells towards neuronal regeneration.[56]  
Unlike magnetic spheres, magnetic capsules are hollow vesicles commonly produced from combinations of 
polymeric solutions and MPs. Magnetic capsules can offer advantages in comparison with microspheres 
depending on the final application or drug delivery strategy. In spheres the bio-agent is entrapped within the 
polymeric matrix while in microcapsules, the bio-agent can be encapsulated within the core that can be in 
liquid phase. Of course that the core features can influence the bio-agent to be more susceptible to oxidation 
and degradation.[1]  
Ma et al. produced thermo-stable magnetic capsules by LbL assembly. Spherical structures were 
polymerized with melamine and formaldehyde, and surface coated with silica where different layers of 
negatively charged SPIONs were deposited by polyelectrolyte LbL assembly. [95]  
The magnetic spheres can be incorporated into a continuous matrix in order to improve the physicochemical 
and biological characteristics of the final system. Thus, magnetic nano- and micro-spheres are obvious 
candidates as building block units in order to fabricate constructs with increasing levels of organization using 
bioengineering techniques like random packing, rapid prototyping or directed assembly. The latter has been 
more deeply investigated since this method takes advantage of attractive inter-particle forces generated by 
MPs.[96] Yoon and colleagues reported the production of protein microspheres using an ultrasonic method 
where magnetic nanoparticles of approximately 25nm were embedded inside and outside the sphere to 
yield nano-functionalization. Another work reported the directed assembly of magnetic nanoparticles using 
a commercial compact template covered with PDMS to obtain cylindrical microstructures.[97] These 
magnetic microspheres were further used as building blocks to produce complex TE structures. 
Liposomes are widely studied in the TERM field due to their chemical and physical versatility, amphiphilic 
properties, low toxicity, fluidity and surface functionalization. Magneto-liposomes (MLs) are liposome vesicles 
in which MPs are surrounded by an artificial self-assembled phospholipid bilayer.  
In MLs, iron oxide MPs can be either coated with a phospholipid bilayer, embedded in the lipid bilayer 
(limited embedding efficiency associated with the particle size) or encapsulated in the internal aqueous 
space of unilamellar vesicles (Figure 1.3 G).[98],[99] Their utility resides in several applications as for MRI 
contrast agents, cell sorting, drug delivery, gene delivery and tissue engineering.  
Indeed, liposomes are perhaps the first carriers which have succeeded in translating from bench to 
bedside.[50] Depending on the final application, the location of the MPs within lipid based systems may be 
a determinant factor. For example, in MRI applications it is better to have NPs within the core of the MLs, 
while for drug delivery the MPs should be between the bilayer, as the core may impact the drug even before 
the membrane became permeable. Additionally the energy required to permeate the membrane is lower 
when the MPs are between the bilayer.[100] 
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The combination of MPs with liposome technologies is envisioned to result in a promising system for 
innovative therapeutic solutions. MLs can host hydrophilic and hydrophobic cargoes in their aqueous 
compartments and bilayer structure, respectively or even in their bilayer/aqueous medium interfaces for 
amphiphilic drugs, being possible to deliver large amounts of a drug to the specific target site. Additionally 
they offer a great possibility to maintain the levels of several drugs in a therapeutic desirable range, and 
they allow to increase the half-life, stability and permeability of several drugs without associated toxicity for 
the neighboring tissues.[101],[102]  
MLS may be designed to be thermosensitive since the in situ generation of heat allows the manipulation of 
liposome permeability and consequently drug release rate.[24] As mentioned before, MPs exhibit 
remarkable heating effects when exposed to an AMF. Combining these systems may provide an excellent 
platform for drug delivery, hyperthermia treatment and MRI tracking. 
Magnetic hybrid liposomes synthetized with liposomal membranes, thermosensitive block copolymers of (2-
ethoxy)ethoxyethyl vinyl ether (EOEOVE), octadecyl vinyl ether (ODVE) and MNPs have shown to enhance 
the release rate of a model drug when exposed to an AMF (360 kHz, 234Oe), without significant drug 
release after the AMF was turned off.[103] Studies with thermosensitive magneto liposomes encapsulated 
with drugs as methotrexate also showed that the agent release was faster at higher temperatures (41ºC) 
when exposed to an EMF.  
In respect to drug targeting for specific tissues, the presence of an additional trigger like pH together with 
the magnetic core of the ML offer great advantages. This is because a magnet can be used to guide MLs 
after an endovenous administration of the drug to the local of action where alterations in the pH can control 
the rate of release.[104] Magnetoliposomes can also be used for tracking using imaging techniques like 
MRI. In a work developed by Soenen et al, cationic MLs were used to magnetically label human blood 
outgrowth endothelial cells in order to follow their homing and integration capacity within the host.[105] 
The cell internalization of magnetoliposomes can also enable to position cells accordingly to a suitable 
pattern stimulated by the actuation of magnetic forces even in 3D template-free approaches. These 
magnetically labeled cells will act as building blocks to be accumulated and distributed accordingly to a 
specific pattern using the magnetic field. This Mag-TE approach using magnetoliposomes has been utilized 
for a number of applications that includes preparation of artificial blood vessels,[13] skeletal muscles,[21] 
and bone tissue formation., [106]  
Magnetic responsive liposomes can be efficiently internalized through electrostatic interactions between the 
ML and the cell membrane, increasing the MNPs accumulation in the target cells.[21] Because cell 
membranes are constituted by a phospholipid membrane, cationic liposomes (with approximately 10 nm) 
can be internalized and further use ML internalized cells to produce cell sheets (Figure 1.3F). Yamamoto et 
al used this system to produce artificial skeletal muscles tissues based on the use of multilayered sheet-like 
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constructs with mouse C2C12 myoblast cells, whose experiment assisted the creation of the magnetic force-
based TERM concept[106]. 
 
1.5.2 Smart Magnetic Gels  
The similarities of the mechanical and compositional characteristics of hydrogels with soft tissues like 
cartilage and their applications in cell or biochemical agent delivery, increases their potential for TERM 
applications as a therapeutic tool for general and personalized medicine.[37],[14] 
The conjugation of hydrogel matrices with inorganic components like MPs can possibly overcome the 
difficulty to accurately control the release rate of an incorporated factor as a response to alterations in the 
environment.[29],[107] In fact, a hydrogel-MPs system has also the advantage of gathering the synergistic 
properties of both elements including the mechanical reinforcement, and site-specificity.[108] Furthermore, 
magnetic hydrogels provide suitable semi-wet, 3D environments for molecular-level biological interactions.  
Methods such as blending-,[109] in situ precipitation[110] and grafting-onto- , [111] have been described 
to produce magnetic hydrogels (Figure 20.3 D, H). The limitation of the blending method relies in a non-
uniform distribution of the MPs within the gel with the risk of losing MNPs from the hydrogel in contact with 
the liquid solutions.[109] In the in situ preparation method, the hydrogels are firstly produced and immersed 
in an aqueous solution containing the ferrous ions, and concentrated into an alkaline solution to produce 
the MNPs. Although MPs can be uniformly distributed into the hydrogel, it is difficult to determine the precise 
MPs concentration. Furthermore, this method is only suitable for stable polymers in alkaline conditions in 
which iron oxides MPs have a tendency to oxidize, and with significant limitations for cell studies.[110]  
The grafting onto method is based on the establishment of a crosslinking between the precursor hydrogel 
and the surface of MPs, that requires functional groups to guarantee the efficiency of the process.[109] 
Because of the presence of covalent bonds, MPs are unlikely to diffuse out of the hydrogel network.  
Blending and in situ precipitation methods normally result in magnetic hydrogels with weak interactions 
leading to a minimal mechanical force reinforcement.[112] In contrary, crosslinking MPs directly to the 
matrix would enhance the mechanical properties of the system, transforming a rather soft, brittle hydrogel 
into an elastomeric material that upon a magnetic field stimulation, may quickly deform with no heat 
evolution or exhaustion.[113]  
Magnetic hydrogel matrices with tunable properties like stiffness, degree of wettability or even surface 
functionalization with bioactive molecules, are interesting templates aiming to achieve specific cell or tissue 
response for TERM applications. Smart magnetic hydrogels have the ability to incorporate and assist the 
release of a multitude of bioactive agents and remotely control the release of these agents through external 
magnetic actuation. Thus, these hydrogels constitute an interesting platform to study the release profiles as 
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well as the control of cell behavior and processes such as angiogenesis in response to mechano-magnetic 
stimuli.[79] Chondroitin sulfate-A (CSA) and carrageenan in combination with iron oxide MNPs and CSA 
coated -iron oxide MNPs demonstrated “on-demand” drug delivery upon the application of an oscillating 
magnetic field.[114] In situ produced magnetic gelatin hydrogels were shown to assist the release of vitamin 
B12 upon EMF of 400 Oe.[115] With this system the vitamin B12 release can be programmably controlled. 
Other magnetic hydrogels as hemicellulose-based hydrogels, also produced by an in situ process, evidenced 
a great potential for controlled drug delivery.[84] Moreover, the Fe3O4 nanoparticles in this system tuned 
the thermal stability, macrostructure, swelling behavior and magnetization of the hybrid hydrogels.  
In another study, the rate of deformation of macroporous alginate ferrogels containing iron oxide NPs 
associated to the presence of an external magnetic field led to a higher release rate of mitoxantrone drug 
after exposure to moderate AMF (every 2 h for a total of 14 hours).[116] Despite these interesting results 
from magnetic hydrogels, only a few systems were proposed for TERM applications.[14],[28],[108] 
Hydrogels with magnetic gradients can also resolve several challenges that exist with the localization of the 
implanted material.[80] For instance, magnetic gelatin membranes crosslinked with MNPs were fabricated 
with a non-uniform magnetization upon AMF application. The spatial variation of the magnetization within 
the scaffold causes the magnetic objects to move, and target delivery is possible by bonding bio-agents to 
the MNPs, without impairing the biocompatibility and others essential properties.[80] Additionally, the 
gelatin membranes have thermic properties tunable by AMF, which unlocks new possibilities for the 
production of biomaterials with thermal gradients.[80] In the work of Campbell and colleagues injectable 
gelling magnetic hydrogels were produced with aldehyde-functionalized dextran SPIONs cross-linked to poly 
(Nisopropylacrylamide) (pNIPAM) and assessed in a mouse model.[14] No chronic inflammation or evidence 
of fibrous capsule formation was observed after a subcutaneous injection combined with an AMF. The 
release rate of bupivacaine hydrochloride, an anesthetic drug, was assessed to be higher in the presence 
of AMF. Thus, smart magnetic hydrogels constitute an advantageous choice for tissue engineering and drug 
delivery since they can resolve the limitations and side effects currently associated with the systemic route 
of administration, including the bio-distribution of the bioactive agent to deliver, the lack of specificity towards 
a particular local, and the necessity of overdosing to achieve proper concentration at a specific location.[117] 
Furthermore, the system can be easily controlled in a spatiotemporal manner through the application of a 
magnetic field. 
The development of tissue-like functional magnetic hydrogels building blocks (Figure 20.4) can be obtained 
through the use relatively simple methodologies and technologies involved in their fabrication, such 
photolithography and molding.[14],[82],[118] Various assembling approaches have been used including 
microfluidics, nanotextured surfaces, and surface tension.[119],[120],[121] These techniques allow 
microtissues scale-up into larger tissues and permit the creation of complex and well-defined 3D- 
architectures.  
Chapter I: General Introduction 
  
22
 
The work developed by Liu and colleagues is an interesting example that took advantage of the robustness 
and the magnetic controllability of microtissues formed with gelatin based materials.[121] Using a 
microfluidic device, individual microtissue units were assembled into larger scale tissue constructs under 
an external magnetic field. With this system, it was also possible to establish a separable co-culture system 
with human hepatocyte cells, which incorporated MNPs and the supporting cells, NIH/3T3 cells, without 
MNPs. Hepatic cells were then separated from the supporting cells through the application of the external 
magnetic field and further implanted in a nude mice. As a magnetic system, these microtissues, in particular 
the MNPs incorporated in the hepatic cells, could be tracked by MRI. 
Building blocks of magnetic hydrogels can also be applied for cell patterning using a simple and low cost 
method.[122] Hydrogels produced with PEG and iron oxide microparticles were placed in a culture plate 
and the cell lines seeded over the hydrogels. The hydrogels prevent the cellular adhesion in the areas they 
were inserted and can be further removed using magnets without affecting the cells. In another work, 
magnetic microparticles were combined with a fibrinogen solution in order to produce a fibrin gel that 
manipulated with magnetic forces produced a defined architecture that could mimic the fibrin fibrils.[123]  
The assembling of soluble fibrin monomers coated with magnetic microbeads into fibrin fibers upon 
magnetic forces stimulation showed that human microvascular endothelial cells were capable to adhere 
and spread along the fibers, suggesting a potential role of magnetic templates in angiogenesis 
strategies.[123] 
1.5.3  Magnetic Responsive 3D Scaffolds 
As described in previous sections, MNPs can be directly incorporated into a 3D scaffold matrix or in the 
cells through cell labeling, if cells are intended to be seeded or cultured on a scaffold prior implantation 
(Figure 1.3 E,H).[124] 
Under the actuation of magnetic forces, an implanted magnetic scaffold adjusts the magnetic force 
distribution leading to a higher concentration of magnetic flux in the surroundings. As a consequence, the 
magnetic elements, as MPs, within a scaffold produce magnetic gradients that generate significant magnetic 
attractive forces in the proximities of the scaffold, which acts as a trapping center, for instance, for 
magnetized cells and with potential to improve the scaffold bioactivity.[80]  
Scaffolds produced from commercial hydroxyapatite, collagen and magnetic nanoparticles, in which RGD 
peptides were incorporated, were shown to respond to a magnetic field with magnetization values as high 
as 15 emu g-1 at 10 kOe.[55] Therefore, the release of pre-loaded biological agents could be triggered when 
a magnetic field was turned on. The actuation of a magnetic field is a dynamic parameter that can be applied 
in both in vitro and in vivo environments, and is preferentially directed to target cells which recognize these 
forces rather than to template structures, like the scaffold and tissue extracellular matrices. Magnetic 
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responsive scaffolds made of polycaprolactone (PCL) were shown to stimulate the migration and 
odontogenesis of human dental pulp cells. [125]  The incorporation of MNPs into a scaffold may help the 
proliferation and differentiation rate of bone cells and thus bone regeneration as bone tissue is capable of 
converting mechanical stress provoked by, for instance, magnetic forces into induced voltage across the 
bone, known as “the piezoelectric effect of bone”.[126] This effect is mainly responsible for the great 
capacity of bone to adapt under impressive mechanical forces. 
The nanofibrous films of poly lactide,- hydroxyapatite and iron oxide NPs were shown to induce a higher 
proliferation rate, faster differentiation and ECM secretion of pre-osteoblast cell line under exposure to static 
magnetic field.[81] The developed scaffold was later implanted in a bone defect model of New Zealand white 
rabbits.[81] The study aimed at assessing osteogenesis upon the application of an external static magnetic 
field. The scaffolds under the external magnetic field promoted higher osteocalcin expression in the bone 
defect, faster achievement of cortical bone and medullar cavity continuity when compared to scaffolds 
without magnetic stimulation.  
The development of a polymeric magnetic scaffold made of starch and PCL fibers (SPCL) with aligned 
structural features in which MNPs were incorporated, was recently described by Gonçalves et al. for tendon 
tissue engineering. These magnetic scaffolds were shown to assist the tenogenic differentiation of human 
adipose-derived stem cells under magneto-stimulation conditions. Afterwards, the magnetic scaffolds were 
implanted in an ectopic rat model, evidencing good biocompatibility and integration within the surrounding 
tissues. [86] 
Mimicking the natural alignment and orientation of tissues has been a challenge in scaffold design and 
fabrication, including in magnetic responsive scaffolds. Highly oriented PLGA/SPIONs fibrous bundles were 
fabricated by electrospinning with oriented fibers to guide cell growth and distribution.[127] Upon the 
application of an EMF, the cell seeded bundles were magnetized, and thus able to be magnetically 
rearranged in order to build a 3D cell-dense engineered tissue with a highly oriented architecture. Cells 
proliferated along the direction of fibers in a similar manner to the native skeletal muscle tissues. 
1.6 Conclusions and Future Perspectives 
With the progress in nanomedicine and in the technological field, several advances have been made that 
highlight the interest and relevance of using magnetic elements like MPs for achieving therapeutic benefits 
in a multitude of TERM strategies from drug delivery, tissue augmentation and replacement to gene and cell 
based therapies.  
Although MPs are already available in the market for diagnosis purposes, the design and manipulation of 
MPs alone or integrated in smart magnetic materials through different processing methodologies to render 
them multi-functional properties, may result in different outcomes on the system biocompatibility and safety. 
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This chapter gathers the most promising features and hot topics on magnetic materials that evidence the 
promisor future of magnetically responsive materials in different areas of TERM. MPs combined with a non-
magnetic 3D template have been proposed as building blocks for tissue engineering constructs to mimic 
tissue structures and morphologies, as agents to mechanically enhance the 3D template properties and as 
controlled delivery agents of cells, drugs, GFs and other biomolecules towards successful tissue regeneration 
instead of assisting repair.  
Smart magnetic systems can be easily controlled through remote actuation and ex vivo stimulation directly 
applied to the organism via magnetic devices, providing potential means to significantly augment the 
performance of magnetic tissue substitutes. Moreover, since the effect of electromagnetic energy is local 
and limited to the site of application, remote control of cell or construct fate through external stimulation 
offers new opportunities for non-invasive clinical therapies with potential for long-term control over the 
release rate of single or multiple drugs during treatment follow up. The most promising features of MP based 
approaches are likely associated to the long term, non-invasiveness and continuous tracking by the use of 
imaging techniques like MRI. 
Future developments will alike focus on increasing the complexity of these systems, making them more 
effective and functional accordingly to biological requirements, using current and state-of-the-art 
technological tools. Additionally, improvements and insights on the mechanisms associated to the actuation 
and stimulation provided by an external magnetic field will be made to precisely control over the intrinsic 
properties of smart magnetic materials like swelling, porosity and structure. In consequence, this will lead 
to well-controlled drug delivery and successful tissue-like substitutes for assisting tissue and organ 
regeneration.  
Besides the design and fabrication of new smart magnetic materials, it is also important to continue 
exploring the biological mechanisms at the cell and organism levels that respond to magnetic elements and 
to the magnetic forces necessary to activate or stimulate cell responses. This dynamic interaction among 
cell/tissue-magnetic system/magnetic forces may be tissue- or cell-specific, may depend on the 
regenerative potential of cell/tissue and on the purpose of the developed system (e.g. therapeutic agent 
release, augmentation device…). Furthermore studies should be performed to understand and determine 
how magnetic forces can safely impact cells and tissues in terms of exposure time, intensity of the field 
without prejudice to the patient and how deep into the tissues layers can local topic magnetic stimulation 
actuate in between the magnetic field and the tissue to regenerate . 
The successful application of smart magnetic materials as biomedical tools for diagnosis and in clinical 
therapies can impact the quality of life of patients worldwide. Furthermore, TERM approaches that provide 
a real-time monitoring system with therapeutic action allowing the follow-up of patients after medical 
intervention without requiring further surgical procedures, through physical contact with medical devices 
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that generate magnetic forces and manipulate their intensity and duration stimulating local tissues, will be 
a major advance in clinical therapies aiming at the treatment of a wide range of injuries and related diseases. 
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2. MATERIALS AND METHODS  
This chapter aims to offer a detailed description of the materials, reagents, cell types and 
experimental techniques used in the work that has been developed under the scope of this Master 
Thesis.  
2.1 Materials 
In this project, magnetic responsive chondroitin sulfate hydrogels enriched with human platelet 
lysate were produced envisioning their application for interfacial tissue engineering (TE) strategies. 
As a proof of concept, we investigated the functionality of developed hydrogels as a construct for 
tendon-to-bone interface (Figure 2.1).  
 
 
Figure 2.1: Schematic representation of the work developed in this Master Thesis. Production of 
met-CS MAGPL hydrogels for A) modulation of the release of bioagents present in PLs through the 
use of an external magnetic field (EMF); B) assemble of met-CS MAGPL Hydrogels as single tendon 
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or bone units and co-culture units aiming at a tendon-to-bone interface model. The impact of 
EMF was also investigated in single and co-culture units. 
 
The selection of the elements to develop such system as well as their methods of production and 
characterization is described in detail in the following sections.  
 
2.1.1 Chondroitin sulfate 
Chondroitin sulfate (CS) is a sulfated glycosaminoglycan composed of a repeating disaccharide 
unit resulting from the copolymerization of D-glucoronic acid with N-acetyl-D-galactosamine, usually 
sulfated in carbon 4 and 6[1]. It is one of the major components of the extracellular matrix (ECM) 
of several connective tissues including bone and tendon, playing a crucial function in the 
maintenance of the structural integrity of the ECM, and for instance in the establishment of 
interactions with collagen[2],[3]. In the ECM, CS is largely associated with glycoproteins, forming 
proteoglycans through covalent bonding. Moreover, CS is capable of absorbing large quantities of 
water due to their polyelectrolyte nature without sacrificing its mechanical properties[4], which 
renders CS great potential to be used as an ECM-mimicking natural material. The presence of 
sulfate (pKa ~ 1) and carboxyl (pKa ~3.3) groups confers to this polymer a strong negative charge 
even at low pH (<3)[5], and thus an inherent ability to attract positively charged molecules like 
growth factors (GFs) through electrostatic interactions. Indeed, CS has been shown to have a 
significant role in intracellular signaling pathways, by binding and mediating the regulation of GFs 
and other bioactive molecules[5]. CS also plays a fundamental role in modulating the stability, 
activity, release, and spatial localization of these GFs, which has been associated with the sulfation 
of the CS molecule[6]. Furthermore, it has been reported to participate in tissue regeneration tuning 
biological properties such as the modulation of anti-inflammatory response, water and nutrient 
absorption and improved wound healing[4]. As a natural polymer, CS evidences interesting 
properties namely biodegradability, chemical versatility and biological performance for tissue 
engineering applications[4]. CS is biodegradable by hyaluronidases (HAses)[7] and 
chondroitinases (CSses)[8], naturally available in the human body, by hydrolysis in the 
hexosaminidic β(1→4) linkages between N-acetyl d-glucosamine and d-glucuronic acid[1]. The 
chemical structure of CS offers multiple modification sites, including carboxyl and hydroxyl groups, 
which are involved in the chemical modification of CS with methacrylate groups. Methacrylated 
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derivatives are versatile and can be more easily converted into matrices with different shapes, such 
as scaffolds, hydrogels or other 3D structures by radical polymerization using photo-initiators, such 
as Irgacure 259 in the presence of UV light[4].  
In this work, chondroitin sulfate was obtained from chondroitin sulfate A sodium salt from bovine 
trachea purchased from Sigma and chemically modified with functional methacrylated groups as 
described in section 2.2.1. 
 
2.1.2  Superparamagnetic Iron Oxide Nanoparticles (SPIONs) 
Superparamagnetic nanoparticles (SPIONs) are widely used in biomedical applications, essentially 
due to their high magnetization in combination with the capacity of not retaining magnetization 
after removal of the magnetic field, thus avoiding aggregation [9]. In fact, these properties make 
SPIONs excellent candidates to provide magnetic responsiveness to non-magnetic tridimensional 
(3D) supportive matrices, such as scaffolds or hydrogels for tissue engineering applications [9]. In 
the particular case of mechano-sensitive tissues like tendon and bone, magnetic stimulation has 
been shown impact the activation of mechanotransduction signaling pathways[10]. Moreover, 
SPIONs incorporated in 3D biomaterials can be further stimulated through the application of an 
external magnetic field (EMF), static or alternating, that cells sense as being mechanical 
(compressive and tensile) forces, replicating the effect of mechanical loading essential for the 
normal functionality of these tissues[11]. Furthermore, the application of SPIONs in the field of 
tissue engineering (TE) has the potential to stimulate and control sub-cellular interactions that are 
not possible using conventional macro and micro scale TE approaches [11]. Moreover, SPIONs 
can render biomaterials the possibility of being manipulated using magnets and thus enabling their 
controlled assembly towards the generation of structures with increasing complexity [12]. In fact, 
the incorporation of SPIONS allows the development of novel and sophisticated biocompatible 
materials with additional features, such as magnetic manipulation, while influencing the cellular 
processes contributing to the creation of tissue-like constructs with improved functionality. 
In this work, magnetic nanoparticles (MNPs) with superparamagnetic behaviour (SPIONs) were 
produced using Fe3+ and Fe2+ salts purchased to Sigma by a co-precipitation method and further 
functionalized with a methacrylated chondroitin sulphate (met-CS) coating. Nevertheless in this 
work SPIONs were referred as MNPs. 
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2.1.3  Platelets Lysate (PL)  
The use of platelet-rich hemoderivates (PRHds), like platelet lysates (PL), platelet-rich plasma (PRP) 
or platelet rich fibrin (PRP), has a vast potential for regenerative strategies[13]. The PRHds have 
been proposed as an alternative cost-effective source of GFs and other molecules with biological 
activity at physiological concentrations[14]. Among PRHds, PL offers several advantages namely 
the removal of platelet debris, thus the possibility of retraction is limited, and the donor to donor 
variation can be minimized using pooled samples obtained from several donors and frozen until 
needed [13]. 
PL can be easily prepared by mechanical disruption of platelet membranes in platelet concentrates 
via thermal shock through cycles of freezing and thawing. Subsequent centrifugation separates the 
platelet debris from the supernatant containing bioactive platelet factors. Among the GFs derived 
from PL, PDGF-BB  has been shown to have a role in fundamental stages of the regenerative 
process and in the processes of osteogenesis[15] and tenogenesis[16]. PL comprises also 
structural proteins involved in the formation of blood clot, such as fibrin, fibronectin and vitronectin 
[13]  acting as provisional ECM matrix during coagulation and providing cues for cell adhesion and 
migration[14].  
PL was prepared from platelet concentrate (PC) obtained by plasma apheresis from volunteer blood 
donors, following a previous established cooperation protocol with Hospital de São João (Porto, 
Portugal). PC with a platelet count of 106 platelets/µL were biologically selected according to the 
Portuguese legislation (Decreto Lei nº 185/2015) and processed as previously described [17],[18]. 
Briefly, PC samples were pooled using 9 donors and subjected to three freeze/thaw cycles. Each 
cycle consisted in a quick freezing by immersion in liquid nitrogen (-196 o C) and thawing in a water 
bath at 37oC. These steps enabled platelet lysis and promoted the release of their protein content. 
In order to eliminate platelet debris, PL was centrifuged at 1400 g for 10 minutes. Finally, the PL 
was aliquoted and stored at -80oC upon needed. Prior to use, PL aliquots were defrosted and 
centrifuged at 2000 rpm for 5 min.   
 
2.2 Methods 
2.2.1 Synthesis of Methacrylated Chondroitin Sulfate 
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Hydrogel matrices are typically formed by chemical or ionic crosslinks. Covalently crosslinked 
hydrogels have become more attractive in TE strategies as their structural stability, mechanical 
properties and degradation can be tuned[19]. In order to generate mechanically and chemically 
robust materials, native chondroitin sulfate can be modified through covalent derivatization of the 
carboxylic acid or hydroxyl group, as occurs in the methacrylation process.  
In the methacrylation process, the hydroxyl group of CS is nucleophilically attacked by the carbonyl 
groups present in the methacrylic anhydride in order to form an ester bond, originating 
methacrylated chondroitin sulfate (met-CS) [20] (Figure 2.2). The methacrylate substitution on CS 
can occurs by a simple and reproducible reaction of CS with methacrylic anhydride in basic 
conditions (ph ~ 8.5). Additionally, the degree of substitution on CS can be controlled by several 
parameters, including the reaction time, reaction temperature, concentration of methacrylic 
anhydride and the pH. [20] 
 
 
 
Figure 2.2:  Methacrylation process of Chondroitin sulfate (CS) using methacrylic anhydride in 
basic conditions.  
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CS methacrylation was performed following a procedure previously described elsewhere [21]. In 
brief, a 1% (w/v) solution of CS was prepared in distilled water and the pH of the solution was 
adjusted to 8.5 using a 5 M NaOH solution. The methacrylation process was performed at 4oC with 
the slowly addition of 10-fold excess molar of methacrylic anhydride (276685, Sigma) to the CS 
solution. The pH was continuously adjusted to 8-8.5 by dropwise addition of NaOH for 24h. Then, 
the resulting solution was precipitated by adding 3-fold reaction volume of cold ethanol (absolute 
ethanol at -20oC, E/0650DF/17, Enzymatic). Three subsequent washing and centrifugation steps 
(6154 g, once for 10 minutes and twice for 5 minutes) using absolute ethanol were performed to 
eliminate unreacted reagents and reaction by-products. The methacrylated chondroitin sulfate 
(met-CS) was then dissolved in distilled water and purified by dialysis (cellulose dialysis 
membranes, average flat width 33 mm, Mw cut-off 14 kDa, Sigma) against distilled water for one 
week, with water renewal three times a day. Finally, the solution was filtered (180µm, Millipore), 
frozen at -80oC and freeze-dried (LyoALfa 10/15 Telstar) for one week. 
 
2.2.2  Production of Methacrylated-Chondroitin Sulfate Nanoparticles (met-CS MNPs) 
2.2.2.1. Production of Magnetic Nanoparticles (MNPs) by Co-Precipitation 
Method 
Magnetic nanoparticles (MNPs) developed for biomedical applications have been synthesized using 
different chemical methods including co-precipitation microemulsions and hidrotermal synthesis, 
among others[9]. In particular, the co-precipitation method allows to produce a large amount of 
MNPs with high purity and excellent magnetic properties in a simple and efficient manner[9]. Thus, 
MNPs were prepared by co-precipitation of Fe2+ and Fe3+ with ammonium hydroxide (NH4OH) 
(05002, Sigma). The chemical reaction of iron oxide nanoparticles formation is described by 
Equation 2.1. 
 
Fe2+ + 2Fe3+ + 8OH        Fe3O4 + 4H2O (Equation 2.1) 
 
Briefly, FeCl3.6H2O (31232, Sigma) and FeCl2.4H2O (220299, Sigma) were mixed to form a 50 mL 
aqueous solution (Millipore water) at a molar ratio of 2:1 (2.25 mmol Fe3+: 1.125 mmol Fe2+) inside 
a triple bottleneck under magnetic stirring and in a nitrogen environment. The mixture was heated 
up to 80 oC and 25% (v/v) of NH4OH was added to the salt solution until the pH of the solution 
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became 10.5. After the addition of NH4OH, the mixture developed a dark color, indicating the 
formation of the MNPs. The solution was further cooled at room temperature for 15 min and the 
dark precipitate was separated from the solution using a permanent magnetic (0.6 T). These 
particles were washed 3 times with Millipore water and 3 times with absolute ethanol by 
centrifugation at 8322 rcf for 15 min in order to remove the unadsorbed Fe2+, Fe3+ cations and the 
NH4OH. 
2.2.2.2. Functionalization of MNPs with a met-CS Coating 
Since iron nanoparticles are easily oxidized in the presence of oxidant agents as oxygen and it is 
important to obtain physically and chemically stable colloidal systems, the MNPs should be 
protected[9]. A common and quite effective strategy is to coat MNPs with a polymer. Polymeric 
coatings may also be used as multifunctional tools to improve the biocompatibility [9], favor water-
dispersibility, prevent both in vitro and in vivo MNP aggregation and, for instance, can be further 
used as a carrier of GF or drugs[22],[23]. Since electrostatic repulsion may occur between charged 
particles, the coating may also provide an electrosteric stabilization effect.  
In this work, MNPs were coated with CS modified with methacrylate groups (met-CS) to chemically 
bind MNPs to a methacrylated CS hydrogel matrix, assisting the development of multifunctional 
3D matrices (Figure 2.3). With this strategy it is possible to overcome a fast loss of MNPs from the 
matrix upon contact with liquid systems, which has been described as a major limitation of 
magnetic hydrogels[24]. Moreover, the met CS will also provide stabilization of MNP, as uncoated 
MNPs tend to aggregate when they are mixed with polymer solutions yet without interfering with 
the magnetic responsiveness of MNPs. 
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Figure 2.3: Schematic representation of the production steps of methacrylated chondroitin sulfate 
(met-CS MNPs). Carbodiimide (EDCI), Adipic Acid Dihydrazide (ADH), Sodium Chloride (NaCl). 
 
In this work, the coating of the MNPs with methacrylated CS (met MNPs) was performed by 
suspending MNPs (3.3 mg/mL) in a solution of 10mM of NaCl and the pH adjusted to 6.3 ± 0.3. 
Afterwards, a 2% (w/v) met-CS solution was added dropwise at a solid/liquid ratio of 20 g/L (which 
means 0.4 mmol of met-CS per gram of MNPs). The pH was re-set to 6.3±0.3 and the coating 
process was carried out for 24h under magnetic agitation in a nitrogen environment. 
The stabilization of the met-CS coating was performed by chemical crosslinking of the carboxylic 
acid moieties of the glucoronic acid with adipic acid dihydrazide (ADH) using a well-established 
carbodiimide (EDCI)-based chemistry[25] (Figure 2.3). Briefly, the pH of the met-CS MNPs 
suspension was set to 4.75 and a solution containing ADH (A0638, Sigma) and EDCI (424331, 
Sigma) corresponding to a molar excess of 2:1 (2 mol of ADH/EDCI for 1 mol of met-CS) was 
added dropwise to the suspension. The pH was continuously adjusted to 4.5 with 0.1 M of HCl 
and the reaction was allowed to proceed at room temperature until no pH variation was observed. 
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The solution was then washed 3 times by centrifugation (8322 rcf, 10 min)  with Milipore water. 
Afterwards, the solution was dialyzed (cellulose dialysis membranes, average flat width 33 mm, 
Mw cut-off 14 kDa, Sigma) for one week against Milipore water.  
2.2.3 Photopolymerization 
Radical photopolymerization is one of the most common methods to produce hydrogels by 
combining the irradiation of a given wavelength and light-sensitive compounds, the photoinitiators. 
The photoinitiator is decomposed into free radicals leading to the formation of covalent bonds 
between precursor molecules in a fast reaction which results in the formation of a hydrogel matrix. 
Particularly, in materials with methacrylated groups under exposure to a light source, free radicals 
react with the C=C present in the methacrylate group creating new radicals called primary 
propagating radicals that initiate polymerization. The reaction is propagated until radical molecules 
are no longer available. UV light-activated polymerization is often used to produce hydrogels for 
biomedical applications [4], allowing spatial and temporal control of the reaction. In addition, UV 
light activated systems allow a fast curing rate and the capacity to initiate the reaction without 
extreme temperatures or environments without oxygen, thus allowing the encapsulation of cells 
without a significantly impact on their viability [26]. Moreover these systems require a UV sensitive 
photoiniatior like Irgacure 2959, commonly used due to a well-established cytocompatibility in 
concentrations below  0.25 % (w/v) [27].  
To prepare the hydrogels Irgacure 2959 was used in combination with a UV light curing system 
(EXFO OmniCure S2000) with a range wavelength of 320-500 nm and a potency of 1.2 mW/cm2 
to establish a stable network between produced met-CS MNPs and the met-CS matrix in order to 
obtain magnetic responsive met-CS hydrogels. 
  
2.2.4 Development of Magnetic Responsive Hydrogels Enriched with Platelet Lysate (met-CS 
MAGPL Hydrogels) 
Methacrylated chondroitin sulfate was used to produce photocrosslinkable met CS hydrogel 
matrices using Irgacure 2959 [2-hydroxy-4’-(2-hydroxyethoxy)-2-methylpropiophenone 98%] 
(410896, Sigma) in the presence of UV light. For that, Irgacure 2959 was dissolved either in 
phosphate buffered saline (PBS) or in PL solutions to a final concentration of 0.25 % (w/v). Then, 
8% (w/v) met-CS was dissolved into these solutions of PBS or PL, vortex and centrifuged for 3 
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minutes at 5000 rpm to remove the oxygen and air bubbles. Afterwards, different concentration of 
met-CS MNPs (100, 200 and 400 µg/mL) were added to the met-CS solution of PBS (met-CS 
MAG, experimental control) or PL (met-CS MAGPL) and sonicated to homogenize the met-CS MNPs. 
Hydrogels without met-CS MNPs were also produced as controls also prepared with a PBS or a PL 
solution and described as met-CS and met-CS PL, respectively (Table 2.1).  
 
Table 2.1: Met CS hydrogel formulations prepared with met-CS MNPs in different solutions used 
in the proposed study. 
 
 
 
After assessing the most promising formulation with met-CS MNPs (200µg/mL) for cellular studies, 
met CS hydrogels enriched with PL were produced in the form of single and double hydrogel units. 
The single and double hydrogel units were envisioned to assess cell behavior in single and co-
culture systems to better understand cell response to the developed hydrogels and also to evaluate 
their potential for interfacial tissue applications.  
The single hydrogel units were produced by injecting 50 µL of a solution with the met-CS PL and 
met-CS MNPs into customized polydimethylsiloxane (PDMS, Sylgard® 184 Silicone Elastomer kit, 
Dow Corning) molds with a square shape of approximately 5×5 mm and 1 mm of height and after 
polymerization by exposure to UV light (320-500 nm, 1.2 mW/cm2, EXFO OmniCure S2000) for 
120 seconds.  
In the case of double hydrogel units, the first hydrogel unit was prepared as describd for the single 
units and placed on the left side of a a PDMS mold with 10mm×10mm and another 50 µL  of 
solution was added to the right side of this mold. The hydrogels units were physically attached into 
a double hydrogel unit by UV light polymerization for 120 seconds.  
 
Met-CS MNPs (µg/ml) 
Solvent of met-CS 0 200 400 
PBS met-CS  Met-CS200 MAG Met-CS400 MAG 
PL met-CS/PL  Met-CS200 MAGPL Met-CS400 MAGPL 
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2.3  Characterization of met-CS by 1H Nuclear Magnetic Resonance (NMR)  
NMR spectroscopy is a technique commonly used to acquire information regarding physical, 
chemical and electronic properties of atoms and molecules. Thus, the degree of modification of 
CS after reaction with methacrylic anhydride was determined by the analysis of 1H NMR spectrum. 
For that, met-CS as well as unmodified CS were dissolved in deuterium oxide (2H2O, D-020-100, 
Laborspirit) at a final concentration of 5mg/mL and their spectra were recorded (Varian Inova 500) 
at 70oC with a frequency of 400.13 MHz and a delay of 1s. 
The degree of methacrylation (Dm) was calculated based on the ratio between the relative area of 
the peaks corresponding to vinyl protons of methacryloyl moiety (at 5.8 and 6.2 ppm) and the 
methyl protons of the acetyl moiety of CS (at ~2.1 ppm). Data on the quantification of the degree 
of methacrylation is presented in Annex I. 
2.4 Physicochemical characterization of met CS MNPs 
2.4.1 Fourier Transform Infrared (FTIR) Spectroscopy 
Infrared spectroscopy allows the study of the interaction of infrared light with matter to withdraw 
chemical and structural information from a sample. In this work, Fourier transform infrared 
spectroscopy (FTIR) was used to qualitatively analyze the coating layer of met-CS MNPs and the 
successful crosslinking between the met-CS with ADH/EDC. Uncoated MNPs were also analyzed 
as experimental controls. The infrared spectra of met-CS MNPs and uncoated MNPs were recorded 
on an IR-Prestige 21 spectrometer (Shimadzu, Scientific Instruments, USA) by averaging 32 scans 
at a resolution of 4 cm−1 over the wavenumber range between 4000 cm−1 and 400 cm−1 at room 
temperature. Samples were prepared using the potassium bromide (KBr) (221864, Sigma) pellet 
technique. Briefly, uncoated MNPs and met-CS MNPs were dried at 105 ºC for 24h. Afterwards, 
these formulations of MNPs were mixed with KBr and processed into pellets before acquisition. 
The regions of the spectra at 1550−1650 cm-1 (corresponding to asymmetric vibration of R-COO-), 
1515−1570 cm-1 (corresponding to NH bending of the amides II), 1630−1680 cm-1 (correspondent 
to amides II, C=O stretching, NH bending), 1715 cm -1 (correspondent to C=O stretch of the ester 
group) and at 1250 cm-1 (the stretch of the SO group) were analyzed. 
Electrokinetic Measurement (Zeta Potential) 
The pH-dependent and ionic strength surface charge of MNPs impact MNPs aggregation in 
aqueous suspension. In suspensions of uncoated MNPs the surface charge  of the iron core that 
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can lead to the formation of positive Fe-OH2+ and negative Fe-OH- while in the case of met-CS MNP 
suspensions, the charge depends on the groups present in the met-CS [22].  
Thus to maximize the electrostatic interactions of MNPs before the met CS coating and to assess 
the stability of both met-CS MNPs and uncoated MNPs suspensions, the zeta potential was verified 
at different pH (3, 5, 7, 10). 
Zeta Potential evaluation was assessed in 0.005% (w/v) solutions of met-CS MNP and uncoated 
MNPs in ultrapure water. The pH of the solutions was adjusted with 0.5 mM of NaOH or HCl. Then 
the resultant suspension was sonicated for 1 minute at room temperature and 1 mL of suspension 
was transferred into a Universal ‘dip’ cell kit (Malvern). The zeta potential was measured at room 
temperature using a ZetaSize Nano-ZS (Malvern Instruments Ltd.). Triplicate samples were 
considered and analyzed for a minimum of 10 scans. 
2.4.2 Determination of the Hydrodynamic Size 
The dimensions of produced met-CS MNPs were measured using a ZetaSizer Nano dynamic light 
scattering equipment (Malvern Instruments Ltd.). The measurements were carried out using a He-
Ne laser with 633nm at 90º scattering angle. Samples were analyzed at a concentration of 
0.05mg/mL and temperature was maintained at 37ºC. Immediately before the analysis, the pH of 
the solutions was adjusted to 7.4 with 0.5 mM of NaOH or HCl, and then sonicated for 1 minute 
at room temperature. The mean diameter was evaluated using the Stokes-Einstein equation. 
Triplicate samples were considered and analyzed for a minimum of 10 scans.  
2.4.3 Thermo Gravimetric Analysis (TGA) 
The percentage of met-CS coating at the surface of the MNPs was assessed by thermal gravimetric 
analysis (TGA) with a simultaneous thermal analyzer (model STA7200, Hitachi). To perform the 
analysis, 2-4 mg of met-CS MNPs were placed in a stainless steel crucible. An empty stainless 
steel crucible was used as reference. The sample was exposed to a rising temperature up to 105oC 
at a rate of 10oC/min under a nitrogen atmosphere. After reaching 105oC, the temperature was 
isothermally held for 10 min in order to remove the water content. To burn the organic part (met-
CS coating) available in the met-CS MNPs under an oxygen environment, the temperature was 
increased to 600oC at a rate of 20oC/min and isothermally maintained during 20 min. The mass 
was recorded as function of the temperature. The weight percentage of met-CS in the MNPs was 
calculated comparing the mass loss after water removal and the remaining mass (Equation 2.2). 
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Uncoated MNPs were used as experimental (negative) controls. Five replicates per condition were 
analyzed.  
% 𝑚𝑒𝑡𝐶𝑆 =
𝑚𝑎𝑠𝑠 𝑎𝑓𝑡𝑒𝑟 𝑤𝑎𝑡𝑒𝑟 𝑟𝑒𝑚𝑜𝑣𝑎𝑙−𝑚𝑎𝑠𝑠 𝑙𝑜𝑠𝑠 𝑎𝑓𝑡𝑒𝑟 𝑤𝑎𝑡𝑒𝑟 𝑟𝑒𝑚𝑜𝑣𝑎𝑙
𝑚𝑎𝑠𝑠 𝑎𝑓𝑡𝑒𝑟 𝑤𝑎𝑡𝑒𝑟 𝑟𝑒𝑚𝑜𝑣𝑎𝑙
 ×100% (Equation 2.2) 
 
2.4.4 Assessment of the Magnetic Properties of Produced MNPs 
The magnetic behavior of MNPs produced in section 2.2.2 was investigated in order to confirm 
their magnetic responsiveness and the superparamagnetic behavior, including magnetic 
remanescence and intrinsic magnetization (magnetic moment) by measuring the magnetization 
curve as function of the applied magnetic field (hysteresis loop). The magnetization measurements 
of met-CS MNPs and uncoated MNPs were assessed in a superconducting quantum interference 
device (SQUID-VSM) magnetometer from Quantum Design, under an applied magnetic field 
between −20.0 and 20.0 kOe at room temperature. Before the analysis, met-CS MNPs and MNPs 
were freeze dried (LyoALfa 10/15 Telstar) for three days. 
2.4.5 Transmission Electron Microscopy (TEM) 
The size of the uncoated MNPs and met-CS MNPs were assessed by Transmission Elecron 
Microscopy TEM (Jeol JEM 1400, Zeiss model EM 10C), upon preparation of solutions with 0.05% 
of uncoated MNPs and met-CS MNPs in Millipore Water. The Electron Microscopy Service of I3S 
(Instituto de Investigação e Inovação em Saúde) prepared and performed the analysis. 
2.5 Characterization of developed met-CS MAGPL Hydrogels 
2.5.1 Low Temperature Scanning Electron Microscopy (cryo-SEM) and TEM 
Scanning electron microscopy is commonly used to determine the microstructure of different types 
of 3D matrices, but fails to recreate the highly hydrated hydrogel structure once it must be dried 
before the analysis[28]. Thus low temperature scanning electron microscopy (cryo-SEM) is an 
alternative technique to analyze the native structure of a hydrogel once the sample is quickly frozen 
in liquid nitrogen thus preserving the intrinsic microstructure.  
In this work the microstructure of magnetic hydrogels enriched with PL (met-CS MAGPL) with 200 
and 400 µg/mL of met-CS MNPs (met-CS200 and met-CS400 MAGPL) were assessed by cryo-SEM. 
Hydrogels without MNPs (met-CS and Met-CS PL hydrogels were used as control.  
Chapter II: Materials and Methods 
 
 
52 
 
The cryo-SEM analysis was performed using a high resolution scanning electron microscope with 
X-ray Microanalysis with a JEOL JSM 6301F/ Oxford INCA Energy 350/ Gatan Alto 2500 
equipment. For that, the hydrogels were rapidly cooled (plunging it into sub-cooled nitrogen, slush 
nitrogen) and transferred under vacuum to the cold stage of the preparation chamber. Further the 
specimen was fractured, sublimated (‘etched’) for 120 sec. at -90°C, and coated with Au/Pd by 
sputtering for 45 sec. The sample was then transferred into the cryo-SEM chamber and the analysis 
was performed at a temperature of -150°C. 
In order to assess the distribution within the met-CS MAGPL hydrogels, TEM analysis was 
performed. It was used met-CS PL hydrogels as control. Hydrogels were fixed with TEM-Fix. The 
Histology preparation and TEM analysis was performed by theElectron Microscopy Service of I3S.  
2.5.2 Dynamic Mechanical Analysis 
Dynamic Mechanical Analysisis commonly used to study the viscoelastic parameters and thus 
assess mechanical parameters of 3D materials such as the storage modulus (E’) that illustrates 
the polymer’s ability to store energy elastically, and the loss modulus (E”) which characterizes the 
polymer’s ability to dissipate energy as heat[29]. The mechanical properties are normally assessed 
when an oscillatory stress is applied to the sample and the response of the material is measured. 
In this work, DMA was used to measure the mechanical/viscoelatic properties of magnetic met-CS 
hydrogels enriched with PL with different concentrations of met-CS MNPs (0, 200, 400 µg/mL) 
using a ATRITEC8000B DMA (Triton Technology, UK) equipped with a compressive mode. 
Hydrogels were immersed in α-MEM culture medium (12000-063, Alfagene) for 15 hours 
supplemented with 10% of fetal bovine serum (FBS) (10270106, Alfagene) and 1% of 
antibiotic/antimitotic (A/A) (15240062, Alfagene) overnight at 37ºC. Hydrogel dimensions were 
accurately measured before analysis. Hydrogels with approximately 5 × 5 mm and a thickness of 
1 mm were assayed. The experiment was performed by applying compression cycles of increasing 
frequency (0.1-10 Hz) under constant strain amplitude (0.1 µm) using a preload of 0.1 % of the 
sample thickness. The assays were performed under simulated physiological conditions by 
immersion of the samples in a Teflon reservoir with α-MEM medium at 37ºC. At least three 
hydrogels per formulation were tested.  
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2.5.3 Effect of magnetic stimulation in the Properties of developed met-CS MAGPL 
Hydrogels  
The influence of magnetic stimulation as well as magnetic activation of met-CS MNPs incorporated 
in the met CS PL hydrogel matrix is an important parameter to be assessed in the developed 
hydrogels. Thus, the impact of a magnetic field in the degradation profile and in the GF release 
from the PL and in the behavior of cells were performed. 
External magnetic stimulation (EMF) was provided by a magnefect nano device (nanoTherics Ltd, 
Keele, UK) under an oscillation frequency of 2 Hz and 0.2 mm of displacement conditions 
composed by an oscillating magnet array system (0.35 T per magnet per hydrogel).  These EMF 
conditions were selected based on previous works developed in our group, which demonstrated 
the application of a magnetic field enhanced the biological performance of hASCs in terms of cell 
proliferation [30] and have also shown to reduce the inflammation and fibrotic tissue formation in 
a rodent model[31].   
The magnetic stimulation induced by the oscillation frequency was maintained without interruption 
during the experimental setup. Samples under in static non stimulating conditions were used as 
experimental negative controls of the influence of magnetic actuation. 
 
2.5.3.1. Swelling and Weight variation upon magnetic Stimulation 
 
The swelling is an important characteristic of a hydrogel defined as the amount of aqueous solution 
that the hydrogel can uptake. It is, therefore an indicator of the polymer network hydrophilicity[32]. 
The stability and degradability of met-CS MAGPL hydrogels upon implantation depends of several 
factors, including erosion, hydrolysis, and enzymatic degradation of the polymeric matrix [32]. 
Thus, hydrogel degradation is another relevant parameter to consider as it can lead to changes in 
mechanical and swelling properties overtime. Ultimately hydrogel matrix degradation impacts the 
structure, stability and the release rate of GFs, as the ones present in PL solution, or cells laden in 
the hydrogel[32]. The magneto-mechanical stimulation resultant from the actuation of an external 
magnetic field may impact the properties of met-CS MAGPL hydrogel as well as the magnetic 
activation of met-CS MNPs present within the met-CS MAGPL hydrogels.  
Thus, in this work, the influence of the actuation of an external magnetic field (EMF) in the swelling 
and degradation profile of the developed met-CS200 MAGPL hydrogels was assessed. The hydrogels 
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were prepared into 5 mm diameter and 5 mm height cylindrical-shaped molds and individually 
placed in the wells of a 24 well plate. Hydrogels were then subjected to magnetic stimulation as 
described in section 2.2.7.3. Hydrogels were retrieved after 3 and 6 hours, 1, 7, 14 and 21 days 
and hydrogels cultured in static non stimulating conditions were used as experimental controls.  
For the swelling assay each sample was incubated in 1.5 mL of PBS at 37º, pH 7.4. After each 
time point, the wet samples were removed from the well and weighted in an analytical balance 
(Denver Instrument, Germany) after the removal of excess surface liquid (wet weight, m WET). 
Then samples were freeze dried during 3 days before measuring the dry weight of the samples (m 
dry). The swelling percentage of the samples was calculated according to equation 2.3: 
 
                                    
𝑚 𝑊𝐸𝑇
𝑚 𝑑𝑟𝑦
× 100   (Equation 2.3) 
 
For the enzymatic degradation assay, the hydrogels were incubated at 37ºC in 1.5 ml of a solution 
of 2.6 U/mL of hyalurodinase (HAse) (H2126, Sigma) in PBS or in PBS alone (experimental 
control). This concentration corresponds to values naturally present in the blood plasma and thus 
this enzymatic value directly relates to human physiological concentrations[33]. In the case of 
weight loss assessment, the procedure was similar to the one described for swelling assay. Briefly, 
the formulations were weighed after each determined time point (m WET) using an analytical 
balance after removal of excess surface liquid. Then, the enzymatic solution or PBS where the 
samples were incubated into, were replaced by fresh solutions until the end of the experimental 
setup. 
The weight loss was calculated based on water uptake, following the equation 2.4:  
 
                                  
𝑚 𝑊𝐸𝑇
𝑚 𝑑𝑟𝑦
× 100   (Equation 2.4) 
 
Where m WET is the weight of the swollen sample and the m Initial the weight of the sample in the 
t=0.  
Samples under static non stimulating conditions were used as experimental controls. The 
experiments were performed using in a minimum of 3 samples of each condition. 
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2.5.3.1. Assessment of Growth Factors Release from Platelet Lysate upon Magnetic 
Stimulation 
PL were used as a soluble pool of growth factors (GFs) and adhesion molecules under the 
hypothesis of occurrence of electrostatic interactions, exploring the attraction between the strongly 
negatively charged polymer (met-CS) and the positively charged GFs to form a biochemical 
enriched hydrogel matrix in which cells can be encapsulated. Moreover, the incorporation of met 
CS MNPs within the CS matrix enriched with PL is expected to allow a remote control over the 
developed system, thus on the GF release, by the application of an external magnetic field (EMF).   
The enzyme-linked immunosorbent assay (ELISA) assay is an analytic enzymatic assay to detect 
the presence of a substance, usually an antigen in solution. The release of specific GFs present in 
PL, namely platelet derived growth factor (PDGF-BB) from hydrogels subjected to EMF stimulation 
and/or enzymatic degradation was assessed by ELISA. PDGF-BB was selected as one of the most 
relevant proteins for TE present in PL, and shown to promote tendon fibroblast proliferation and 
matrix remodeling during tendon healing[34].  Briefly, the technique consists in the immobilization 
of a specific antibody (capture antibody) to the solid surface of a 96-well plate that will bind to the 
interest molecule. Then, a specific antibody (the detection antibody) is applied and will bind to the 
molecule of interest. Then, a solution containing the substrate of the enzyme is added to produce 
a detectable signal (color change) that will be used to quantify the antigen available in the solution. 
The content of PDGF-BB was assessed according to the manufacturer’s instructions (Pepro Trech). 
For this, met-CS200 MAGPL hydrogels were prepared incubated in PBS or in a HAse solution (2.6 
U/ml) at 37ºC under the stimulation of EMF (section 2.2.7.3.). PDGF-BB was quantified in the 
incubation medium after 15, 45 and 90 minutes, 3 and 6 hours, 1, 2, 4, 7 and 10 days . Samples 
in static non EMF conditions were considered experimental controls. The PDGF-BB was quantified 
using a minimum of 3 samples per condition. 
2.6 Biological assays  
2.6.1 Isolation and culture of cells 
Cells used in the present work were isolated from human tissues. For this purpose, human 
lipoaspirates and tendon tissue samples were collected under an established protocol with Hospital 
da Prelada (Porto, Portugal). All samples were obtained under informed consent, according to the 
Declaration of Helsinki and the protocols were approved by the ethical committee of the Hospital. 
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Samples were transported in a 10% (v/v) A/A in PBS solution inside a sterile container and 
processed as described below. 
 
2.6.1.1. Human Tendon Derived Cells (hTDCs) 
Human tendon derived cells (hTDCs) isolated from tendon tissues are a heterogeneous population 
of cells which have shown to assist the regeneration of tendon-to-bone interface in animal models 
[35], and thus a promising source to be used in tissue interface of tendon-to-bone.  Human TDCs 
will be used in this work to colonize the tendon hydrogel unit in both single and double unit systems 
[36].  
Human TDCs were collected from tendon samples from patients undergoing orthopedic 
reconstructive surgeries. Briefly, samples were firstly washed with DPBS containing 10% (v/v) of 
A/A and surrounding non-tendon tissue was removed using a surgical blade. Afterwards, samples 
were minced and digested with a solution of 0.1% (w/v) collagenase type I solution (Z56.LS004196, 
Sigma) during 1 hour at 37oC under agitation (200 rpm). The digested tissue was filtered with a 
cell strainer (100 µm), centrifuged (1200 rpm, 5min, 5ºC) and the resultant cellular suspension 
was expanded in basal medium composed by α MEM with 10% (v/v) FBS, 1% A/A (v/v) and Na2CO3  
at 37oC, 5% CO2. 
Cells were cryopreserved until usage. Human TDCs in 2D cultures were further characterized by 
flow cytometry analysis (data not shown). In all experimental assays, hTDCs were used in passage 
2 to 4. Cells used during these experiments were characterized by flow cytometer (data not shown). 
  
2.6.1.2. Human Adipose Stem Cells (hASCs) 
In recent years, adipose tissue has been gaining attention as a stem cell source with therapeutic 
potential for a wide range of pathologies due to the high self-renewal and multilineage differentiation 
potential of adipose derived stem cells (ASCs), including their commitment and differentiation 
towards osteoblastic like cells under appropriate stimulation. Moreover, human ASCs (hASC) are 
obtained using less invasive procedures and in larger quantities in comparison with bone marrow 
derived stem cells[37].  
Thus, hASCs that will be osteogenically stimulated with standard osteogenic inductive medium, 
were envisioned to colonize the bone hydrogel units in single and double unit systems.  
Human ASCs used during the experimental setup were isolated from lipoaspirate samples of 
female donors. In order to disrupt the connective tissue to release the cells, the sample was 
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digested with a solution of 0.05% (w/v) collagenase type I in PBS under mild agitation during 45min 
at 37oC. Then, the suspension was filtered (100µm, Sigma), centrifuged (2587rpm, 10 minutes) 
to separate the stromal vascular fraction (SVF) and washed with lysis buffer for removal of the red 
blood cells. Further the solution was centrifuged at 2587rpm for 10 min and the resultant cellular 
suspension was expanded in basal medium as described in the previous section at 37oC, 5% CO2. 
Cells were cryopreserved and expanded upon needed.  Experimental assays were performed with 
hASCs in passage 3 to 5. 
 
2.6.1.3. Pre Osteogenic differentiation of hASCs 
Human ASCs were pre-differentiated into pre-osteoblastic like cells (pre-Ost) before laden in the 
met-CS MAGPL hydrogels. Human ASCs were cultured in osteogenic medium to induce the 
osteogenic phenotype, that was composed of α-MEM, 10% FBS, 1%A/A supplemented with 
osteogenic factors, namely dexamethaxone (10-8 M, Sigma-Aldrich), ascorbic acid ( 50µg/mL, 
Sigma-Aldrich) and β-glycerophosphate (10mM, Sigma- Aldrich) for 14 days before being cultured 
in the developed hydrogel units. To assess hASC commitment toward the osteogenic phenotype 
flow cytometry was performed after 14 days in osteogenic culture. In the following assays, pre-
osteoblastic like cells were designed as pre-Ost cell. 
2.7 Assessment of the Cytocompatibility of Developed MNPs in the presence of HASCs 
To assess the influence of met CS MNPs in cellular processes, namely metabolic activity and 
proliferation rate, hASCs were seeded in 24-well tissue culture plates at a density of 103 cells per 
cm2 in basal medium. After 24 h in culture, the culture medium was replaced with 1 mL of α MEM 
medium containing different concentrations of MNPs (200, 400 µg/mL). Then, hASCs cultured 
with MNPs for 1, 3 and 7 days and characterized for metabolic activity by Alamar Blue (BUF012B, 
Arium) and for cellular proliferation using a dsDNA quantification kit (P7589, Alfagene). Met-CS 
MNPs were compared to uncoated MNPs. Cells cultured in the absence of MNPs were used as 
controls of the experiment. 
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2.8 Encapsulation of hTDCs and/ or Pre-Ost in the met-CS MAGPL hydrogel tendon 
and bone units 
After reaching the sufficient cell number for encapsulation in the met-CS MAGPL hydrogels, hTCs 
and pre-Ost cells were detached using tripLE Express (126905-028, Alfagene) and counted using 
a hemocytometer. Cells were then centrifuged at 1200rpm for 5 minutes and suspended in a 
density of 2×106 /mL in basal culture medium. 
The behavior of cells laden in met-CS200 MAGPL hydrogels was assessed in single (tendon or bone 
units) and co-cultures of hTCs and Pre-Ost cells (tendon-bone interface units). 
To prepare the tendon, bone and co-culture units, hTDCs and pre-Ost cells were gently mixed with 
met-CSPL solution containing the photoinitiator as described in section 2.2.3.1. Afterwards, 200 
µg/mL of met-CS MNPs (prepared as described in section 2.2.2.) was added and vortex to 
homogenize the met-CS MNPs.  
In the case of tendon and bone single units, 50 µL of the prepared solution containing hTCs or pre-
Ost cells was injected into a PDMS mold with 5mm×5mm and UV light polymerized for 120 
seconds.  
In the case of co-culture units, 50 µL of the solution containing hTDCs was injected in the PDMS 
mold and UV light polymerized for 120 seconds. Then, the formed hydrogel (tendon unit) was 
placed into the left side of another PDMS mold (10mm×10mm) and 50 µL of a solution containing 
pre-Ost cells was added to the right  side of the 10mm×10mm  mold. The hydrogels units were 
physically attached through polymerization of the bone and tendon units by UV light for 120 
seconds, forming a co-culture tendon-bone interface unit.  
Both single and co-culture units were gently removed from the mold and cultured in 24 well plate 
in basal medium during 1, 7, 14 and 21 days in EMF conditions . Formulations cultured in non-
stimulating conditions were used as experimental control of magnetic actuation. 
Single Met-CS MAGPL hydrogel laden with hTDCs or pre-Ost cells (single cell-hydrogel units) were 
used as controls.  
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2.9 Characterization of the Cell Behavior in the Developed Systems  
2.9.1 Alamar Blue Assay 
Alamar Blue cell viability reagent is a non-toxic colourimetric assay that quantitatively permit the 
assessment of cell viability. This method uses a cell permeable compound, resazurin that after cell 
membrane penetration is reduced to resorufin resulting in a fluorescent molecule. Metabolically 
active cells continuously convert resazurin to resorufin thus giving information about the viability 
and cytotoxicity [38].  
The metabolic activity of hASCs in the presence of met-CS MNPs (cytocompatibility assay) and in 
cell laden met-CS200 MAGPL hydrogels were verified after 1, 3 and 7 days. Regarding the cell-laden 
met-CS MAGPL hydrogels, the metabolic activity of single and co-culture units was assessed in the 
day 1, 7, 14 and 21. Briefly, a solution of 10 % (V/V) of Alamar Blue in α-MEM medium was 
prepared and incubated for 15 minutes at 37ºC.  Before the analysis, the cells cultured in the 
presence of different concentrations of met-CS MNPs and encapsulated in the single and co-culture 
units were washed 2 times in PBS and 800 µL of the solution previously prepared was added to 
the samples. The samples were then, incubated for 5 hours at 37ºC in 5% CO2 protected from the 
light. The fluorescence was read in a microplate reader (Synergy HT, BIO-TEK) with an excitation 
of 530 nm and an emission of 590 nm. Six biological replicates were considered for each condition 
per timer point.  
2.9.2 Cellular Content assay (dsDNA quantification) 
The cellular content assay is a quantitative technique that uses an ultra-fluorescence compound, 
Picogreen, that binds to double-strand DNA to quantitatively determine the dsDNA concentration 
of a given sample measured by a Microplate reader. 
The proliferation rate of hASCs cultured with different concentrations of met-CS MNPs was 
assessed after 1, 3 and 7 days. The cellular proliferation in the single (bone or tendon) and co-
culture (tendon-bone units) was performed after 1, 7, 14, 21 days in culture.  
To perform the analysis, the samples of interest were washed two times with DPBS and 1 mL of 
ultra-pure water was added in order to induce cellular lysis. Then the cellular suspension was mixed 
and each sample was frozen at -80ºC. Prior to the analysis, the samples were thawed and milled 
in an ultrasonic processor (VCX-130PB-220, Sonics) to rupture the cell membrane. Experimental 
samples and standards (concentrations from 0-2 µg/mL) were gently mixed with a PicoGreen 
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solution (1:200 dilution, P7589, Alfagene), placed in a white opaque 96 well-Plate (734-1662, 
VWR) and incubated for 10 minutes protected from light. The experimental setup was followed 
accordingly with manufacturer´s instructions. The fluorescence was read in a microplate reader 
with an excitation of 485 nm and an emission of 530 nm. The concentration of dsDNA was 
assessed by comparing the fluorescence intensity of a sample with the generated standard curve 
(obtained with the DNA standards). At least 3 biological replicates were considered for each 
condition per time point.  
2.9.3 Immunolabeling of tendon and bone related proteins 
Immunolabeling for Collagen I (ab34710), Osteopontin (ab14175) and Tenascin-C (ab6393) was 
performed in single units after 7 and 21 days and in co-culture units after 21 days in culture. All 
primary antibodies were purchased to Abcam. To perform the analysis, the antibodies were diluted 
in ratio of 1:200, 1:100 and 1: 200 for collagen I, osteopontin and tenascin-C respectively, and 
incubated 1 hour at room temperature. Alexa Fluor 488 was used as fluorescent secondary 
antibody from rabbit (1754421, Alfagene) for collagen I and mouse (1741782, Alfagene) for 
tenascin-C and osteopontin. Moreover DAPI (4', 6-diamidino-2-phenylindole) (40009, VWR) and 
Phalloidin red stains (Phalloidin–Tetramethylrhodamine B isothiocyanate) were used in dilutions 
1:1000 and 1:200 respectively. After, the samples were analyzed in an inverted confocal 
microscope (TCS SP8, LEICA) equipped with argon/He-Ne laser sources. 
2.9.4 Gene Expression Analysis by Real-Time Polymerase Chain Reaction (RT-
PCR) 
The expression of the genes tenascin, decorin, osteopontin, collagen I was quantitatively assessed 
by real-time polymerase chain reaction (RT-PCR) on RNA isolated from pre-Ost cells and hTCs, and 
co-cultures 7, 14 and 21 days after the encapsulation in met-CS MAGPL hydrogels. In the case of 
the co-culture tendon bone interface units, each hydrogel was sectioned in three parts as illustrated 
in the Figure 2.4. Four independent biological replicates for each time point were analyzed. 
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Figure 2.4. Representative scheme of the sections part of the co-culture system for gene expression 
analysis by real-time polymerase chain reaction (RT-PCR). The section one represents the part of 
the hydrogel encapsulating hTDCs, the second part the interface between the hydrogel 
encapsulating hTDCs and pre-Ost and the third section relates to the hydrogel encapsulating pre-
Ost cells. 
 
Total RNA was isolated from cells using the TRI Reagent® RNA Isolation Reagent (Sigma-Aldrich) 
according with the manufacturer’s instructions. The yield and purity of RNA isolation was 
determined by spectrometry using the NanoDrop 1000 Spectrophotometer (ThermoScientific). The 
cDNA was synthesized using 100 pg of RNA as template and the qScript™ cDNA Synthesis Kit 
(Quanta BioSciences). The primers, listed in Table 2.2 were designed using the primer-BLAST tool 
available at http://www.ncbi.nlm.nih.gov/tools/primer-blast. To avoid the amplification of genomic 
DNA or pre-RNA (non-spliced RNA), the primers were designed in order to span the exon-exon 
junctions. Target genes were normalized to the reference housekeeping GAPDH gene according to 
Livack’s method [39]. The analysis was performed on a real time Polymerase Chain Reaction (RT-
PCR) Mastercycler (Realplex, Eppendorf).  
 
Table 2.2. List of primers used for RT-PCR expression analysis of osteogenic and tendon related 
genes. The primers were designed using the primer-BLAST web tool 
 
NCBI 
Reference 
Sequence 
Gene product Gene 
Short 
name 
Primer sequence Product 
length 
[bp] 
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NM 
001040058.1 
Secreted 
phosphoprotein 1 
(Osteopontin) 
OPN CAGACCTGACATCCAGTACCC 
GGTCATCCAGCTGACTCGTT 
173 
NM 
001920.3 
Decorin DCN CAGCATTCCTCAAGGTCTTCCT 
GAGGCCATTGTCAACAGCA 
150 
NM 
000088.3 
Collagen alpha-1(I) 
chain 
COLIA1 CCCCAGCCACAAAGAGTCTAC 
TTGGTGGGATGTCTTCGTCT 
150 
NM 
001256799.1 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
GAPDH GGGAGCCAAAAGGGTCATCA 
GCATGGACTGTGGTCATGAGT 
198 
 
2.10  Statistical analysis 
Results are presented as mean ± standard deviation. The statistical analysis of data was performed 
using GraphPad Prism 6 software. Statistical analysis was carried out using 2-way ANOVA for 
significant differences among studied conditions followed by Turkey's multiple comparison test. A 
minimum of 95% confidence interval was considered for all measurements (p<0.05). Statistical 
significant values and associated degree of confidence (p<0.05) are denoted by symbols 
represented in the graphs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II: Materials and Methods 
 63 
 
2.11 References 
[1] Silva C, Novoa-Carballal R, Reis RL, Pashkuleva I. Following the enzymatic digestion of chondroitin sulfate 
by a simple GPC analysis. Analytica Chimica Acta. 2015;885:207-13. 
[2] Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. 
Critical reviews in biomedical engineering. 2012;40:363-408. 
[3] Yang G, Rothrauff BB, Tuan RS. Tendon and Ligament Regeneration and Repair: Clinical Relevance and 
Developmental Paradigm. Birth defects research Part C, Embryo today : reviews. 2013;99:203-22. 
[4] Li Q, Williams CG, Sun DD, Wang J, Leong K, Elisseeff JH. Photocrosslinkable polysaccharides based 
on chondroitin sulfate. Journal of biomedical materials research Part A. 2004;68:28-33. 
[5] Lim JJ, Temenoff JS. The effect of desulfation of chondroitin sulfate on interactions with positively 
charged growth factors and upregulation of cartilaginous markers in encapsulated MSCs. Biomaterials. 
2013;34:5007-18. 
[6] Deepa SS, Umehara Y, Higashiyama S, Itoh N, Sugahara K. Specific molecular interactions of 
oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a 
physiological binding partner in the brain and other tissues. The Journal of biological chemistry. 
2002;277:43707-16. 
[7] Honda T, Kaneiwa T, Mizumoto S, Sugahara K, Yamada S. Hyaluronidases Have Strong Hydrolytic 
Activity toward Chondroitin 4-Sulfate Comparable to that for Hyaluronan. Biomolecules. 2012;2:549-63. 
[8] Smith AJ, Greenman J, Embery G. Detection and possible biological role of chondroitinase and 
heparitinase enzymes produced by Porphyromonas gingivalis W50. Journal of Periodontal Research. 
1997;32:1-8. 
[9] Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic Nanoparticles: Design and Characterization, Toxicity 
and Biocompatibility, Pharmaceutical and Biomedical Applications. Chemical Reviews. 2012;112:5818-78. 
[10] Yuge L, Okubo A, Miyashita T, Kumagai T, Nikawa T, Takeda S, et al. Physical stress by magnetic force 
accelerates differentiation of human osteoblasts. Biochemical and biophysical research communications. 
2003;311:32-8. 
[11] Santos LJ, Reis RL, Gomes ME. Harnessing magnetic-mechano actuation in regenerative medicine and 
tissue engineering. Trends in biotechnology. 2015;33:471-9. 
[12] Xu F, Wu CA, Rengarajan V, Finley TD, Keles HO, Sung Y, et al. Three-dimensional magnetic assembly 
of microscale hydrogels. Advanced materials (Deerfield Beach, Fla). 2011;23:4254-60. 
[13] Crespo-Diaz R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J, et al. Platelet Lysate Consisting 
of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal 
Stability. Cell Transplantation. 2011;20:797-811. 
Chapter II: Materials and Methods 
 
 
64 
 
[14] Tsay RC, Vo J, Burke A, Eisig SB, Lu HH, Landesberg R. Differential growth factor retention by platelet-
rich plasma composites. Journal of oral and maxillofacial surgery : official journal of the American 
Association of Oral and Maxillofacial Surgeons. 2005;63:521-8. 
[15] Santo VE, Duarte ARC, Popa EG, Gomes ME, Mano JF, Reis RL. Enhancement of osteogenic 
differentiation of human adipose derived stem cells by the controlled release of platelet lysates from hybrid 
scaffolds produced by supercritical fluid foaming. Journal of Controlled Release. 2012;162:19-27. 
[16] Carvalho Ade M, Badial PR, Alvarez LE, Yamada AL, Borges AS, Deffune E, et al. Equine tendonitis 
therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial. Stem cell 
research & therapy. 2013;4:85. 
[17] Santo VE, Gomes ME, Mano JF, Reis RL. Chitosan-chondroitin sulphate nanoparticles for controlled 
delivery of platelet lysates in bone regenerative medicine. Journal of tissue engineering and regenerative 
medicine. 2012;6 Suppl 3:s47-59. 
[18] Babo P, Santo V, iacute, tor E, Duarte ARC, Correia C, et al. Platelet lysate membranes as new 
autologous templates for tissue engineering applications. Inflammation and Regeneration. 2014;34:033-
44. 
[19] Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering 
applications. Tissue engineering Part B, Reviews. 2008;14:149-65. 
[20] Wang L-F, Shen S-S, Lu S-C. Synthesis and characterization of chondroitin sulfate–methacrylate 
hydrogels. Carbohydrate Polymers. 2003;52:389-96. 
[21] Smeds KA, Pfister-Serres A, Miki D, Dastgheib K, Inoue M, Hatchell DL, et al. Photocrosslinkable 
polysaccharides for in situ hydrogel formation. Journal of biomedical materials research. 2001;54:115-21. 
[22] Tóth IY, Veress G, Szekeres M, Illés E, Tombácz E. Magnetic hyaluronate hydrogels: preparation and 
characterization. Journal of Magnetism and Magnetic Materials. 2015;380:175-80. 
[23] Gupta AK, Curtis ASG. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction 
studies with human fibroblasts in culture. Journal of Materials Science: Materials in Medicine. 2004;15:493-
6. 
[24] Barbucci R, Giani G, Fedi S, Bottari S, Casolaro M. Biohydrogels with magnetic nanoparticles as 
crosslinker: characteristics and potential use for controlled antitumor drug-delivery. Acta Biomater. 
2012;8:4244-52. 
[25] Kuo JW, Swann DA, Prestwich GD. Chemical modification of hyaluronic acid by carbodiimides. 
Bioconjugate chemistry. 1991;2:232-41. 
[26] Fairbanks BD, Schwartz MP, Bowman CN, Anseth KS. Photoinitiated polymerization of PEG-diacrylate 
with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. 
Biomaterials. 2009;30:6702-7. 
Chapter II: Materials and Methods 
 65 
 
[27] Bahney CS, Lujan TJ, Hsu CW, Bottlang M, West JL, Johnstone B. Visible light photoinitiation of 
mesenchymal stem cell-laden bioresponsive hydrogels. Eur Cell Mater. 2011;22:43-55; discussion  
[28] Binh VT, Purcell ST, Semet V, Feschet F. Nanotips and nanomagnetism. Applied Surface Science. 
1998;130–132:803-14. 
[29] Sapir Y, Cohen S, Friedman G, Polyak B. The promotion of in vitro vessel-like organization of endothelial 
cells in magnetically responsive alginate scaffolds. Biomaterials. 2012;33:4100-9. 
[30] Goncalves AI, Rodrigues MT, Carvalho PP, Banobre-Lopez M, Paz E, Freitas P, et al. Exploring the 
Potential of Starch/Polycaprolactone Aligned Magnetic Responsive Scaffolds for Tendon Regeneration. 
Advanced healthcare materials. 2015. 
[31] Santos L, Silva M, Goncalves AI, Pesqueira T, Rodrigues MT, Gomes ME. In vitro and in vivo assessment 
of magnetically actuated biomaterials and prospects in tendon healing. Nanomedicine (Lond). 
2016;11:1107-22. 
[32] Caliari SR, Burdick JA. A practical guide to hydrogels for cell culture. Nat Meth. 2016;13:405-14. 
[33] Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy 
probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. International Journal of 
Pharmaceutics. 2003;262:1-11. 
[34] Thomopoulos S, Zaegel M, Das R, Harwood FL, Silva MJ, Amiel D, et al. PDGF-BB released in tendon 
repair using a novel delivery system promotes cell proliferation and collagen remodeling. Journal of 
orthopaedic research : official publication of the Orthopaedic Research Society. 2007;25:1358-68. 
[35] Hashimoto Y, Yoshida G, Toyoda H, Takaoka K. Generation of tendon-to-bone interface "enthesis" with 
use of recombinant BMP-2 in a rabbit model. Journal of orthopaedic research : official publication of the 
Orthopaedic Research Society. 2007;25:1415-24. 
[36] Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, et al. Identification of tendon 
stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007;13:1219-27. 
[37] Feisst V, Meidinger S, Locke MB. From bench to bedside: use of human adipose-derived stem cells. 
Stem Cells and Cloning : Advances and Applications. 2015;8:149-62. 
[38] Rampersad SN. Multiple Applications of Alamar Blue as an Indicator of Metabolic Function and Cellular 
Health in Cell Viability Bioassays. Sensors (Basel, Switzerland). 2012;12:12347-60. 
[39] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and 
the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001;25:402-8. 
 
 
 
 
 
Chapter II: Materials and Methods 
 
 
66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
67 
 
 
 
                CH 
 
 CHAPTER III 
MULTIFUNCTIONAL MAGNETIC-RESPONSIVE HYDROGELS TO 
ENGINEER TENDON-TO-BONE INTERFACES 
This chapter is based on the following publication:  
Silva ED, Babo P, Costa-Almeida R, Domingues RMA, Mendes B, Rodrigues MT, Granja 
PL, Gomes ME “Multifunctional Magnetic Responsive Hydrogels to Engineer Tendon-to-
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3. MULTIFUNCTIONAL MAGNETIC-RESPONSIVE HYDROGELS TO ENGINEER 
TENDON-TO-BONE INTERFACE 
3.1 Abstract 
Photocrosslinkable natural based hydrogel matrices have received great interest for tissue 
engineering strategies, especially because they provide versatile systems that can be potentially 
used in diverse applications. Nevertheless, to engineer complex tissues and/or tissue interfaces, it 
is necessary to develop systems that can accommodate various functionalities. Such systems could 
also benefit from the possibility of being remotely controlled and/or further manipulated ex vivo.  
This work reports on the development of a photocrosslinkable magnetic responsive hydrogel based 
on a methacrylated chondroitin sulfate (met-CS) matrix enriched with platelet lysate (PL), 
envisioning the generation of tunable hydrogel building blocks to engineer tissue interfaces, such 
as tendon-bone. To provide magnetic responsiveness, magnetic nanoparticles (MNPs) coated with 
met-CS (met-CS MNPs) were produced to enable their linkage to the hydrogel matrix. The produced 
met-CS MNPs were characterized and subsequently incorporated in PL enriched met-CS hydrogel 
matrices.  The actuation of an external magnetic field (EMF) to modulate the properties of the 
system was then investigated. The application of an EMF was shown to modulate the swelling, 
degradation and release of growth factors naturally present in the PL. Moreover, the effect of EMF 
in hydrogels laden with either pre-osteoblasts differentiated from human adipose derived stem cells 
(pre-Ost) or human tendon cells (hTDCs), was assessed in single and co-culture systems. Both 
hTDCs and pre-Ost cells were able to proliferate, colonize and express tendon and bone related 
markers in the developed hydrogels. Moreover EMF seems to impact cell morphology and the 
synthesis of a tendon- and bone- like ECM, whose effect is highlighted in co-culture systems. 
Together, these results suggest that developed hydrogel represents a potential cell laden system 
for tissue engineering in which the properties can be externally modulated through EMF stimulation.  
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3.2 Introduction 
Progresses in regenerative medicine and tissue engineering [1] have been deeply associated to the 
development of functional biomaterials for guiding tissue regeneration[2],[3]. Nevertheless, these 
systems could benefit from the addition of functionalities that would allow manipulate and remotely 
control specific components of the construct. This is of particular importance for  bioengineering 
tissue interfaces such as tendon-to bone, tendon-muscle and osteochondral, that are constituted 
by distinct cell types and extracellular matrix (ECM) components, with a critical interdependence 
in terms of structure, function, organization and composition[4], [5]. This requires for approaches 
that allow engineer constructs enabling to spatially distribute cell populations and establish cell to 
cell and cell-environmental interactions in a temporal and spatial resolved environment 
(mechanical and biochemical). In the particular case of tendon-to-bone interface or enthesis, which 
is severely prone to injury [6], once they are mechano-sensitive tissues [7],[8] the application of a 
mechanical stimulus that may assist the recapitulation, to some extent, of the forces that are 
exerted on the cells in vivo. The actuation of a magnetic field has shown to provide essential 
mechanical cues to induce and activate the interactions between cells and ECM via 
mechanosensing pathways[9]. Furthermore, growing evidence suggests that magnetic forces 
enhance vital functions of cells including adhesion [10], proliferation and differentiation [11]. Thus, 
the fabrication of magnetic tendon-specific and bone-specific units with tunable features may assist 
the development of a gradient-like “tissue”, closer mimicking the native interface. In this case, 
magnetic forces could be used not only to tune the behavior of laden cells[12] but also to  externally 
control the properties of the system, like degradation and swelling.  
In this particular point, the incorporation of iron-based magnetic nanoparticles (MNPs) with a 3D 
cell carrier, such as a hydrogel matrix, may constitute a great option to obtain functional building 
blocks structures with ability to modulate biochemical, physical and mechanical stimuli.  However, 
strategies currently used to produce mag-gels present several limitations, including the risk of 
MNPs leaching from the hydrogel upon contact with a liquid environment[13] or in the case of 
MNPs cross-linked to the matrix the cytotoxicity associated with the process[14]. In the present 
study we propose to develop a magnetic responsive hydrogel composed of a methacrylated 
chondroitin sulfate (metCS) matrix enriched with platelet lysate, in which met-CS coated MNPs 
were covalently linked to the matrix. Therefore, with this incorporation the use of magnetic forces 
might be used to externally control the properties of the system like and to tune the behavior of 
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studied cells [12].  Moreover in this case CS was chosen as the main element of the hydrogel 
matrix because this natural polymer is a crucial component of the extracellular matrix (ECM) in 
several connective tissues, including tendon and it is also available in bone, and it is known to have 
a crucial function in maintaining the structural integrity and ECM [15]. Also, CS presents a strong 
negative charge and thus an inherent ability to attract positively charged matrix molecules like 
growth factors (GFs) [16].  Once, platelet Lysate (PL)  is constituted by a pool of mitogenic 
molecules  that are released from degranulation of platelets to trigger the process of regeneration 
[17], they could be an effective and cost-effective alternative to have a pool of GF and other bioactive 
molecules to trigger[18] the orchestration of the regeneration process in such complex interfaces 
as tendon-to-bone[19].  In addition, the use of an external magnetic field in combination with the 
presence of MNPs in the matrix could be used to tune the release of GF available in PLs from the 
hydrogel units. 
The developed hydrogels units were used to create 3D magnetic responsive constructs that could 
be externally manipulated through the use of magnetic field for tendon-to-bone interface and 
extensively characterized in terms mechanical properties, swelling, degradation profile, the impact 
of an external magnetic field to modulate these intrinsic properties and also its biological 
performance. To assess such features, hydrogel units were either encapsulated with human 
adipose derived stem cells (hASCs) previously osteogenic differentiated for 14 days or with human 
tendon cells (hTCs) were used. The 3D constructs composed of two interconnected units (bone 
and tendon units) were assembled and cultured for 21 days upon magnetic stimulation and 
characterized in terms of proliferation, metabolic activity, osteo and tendon-related genes and 
protein expression. 
 
3.3 Materials and Methods 
3.3.1  Preparation of Platelet Lysate  
PL was prepared from platelet concentrate (PC) obtained by plasma apheresis from volunteer blood 
donors, following a previous established cooperation protocol with Hospital de São João (Porto, 
Portugal). PC with a platelet count of 106 platelets/µL were biologically selected according to the 
Portuguese legislation (Decreto Lei nº 185/2015) and processed using 10 donnors as previously 
described[18].  
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3.3.2  Synthesis of Methacrylated Chondroitin Sulfate 
The methacrylation of chondroitin sulfate (CS), (Chondroitin sulfate A sodium salt from bovine 
trachea, Sigma) was performed following a procedure described elsewhere20. Briefly, the pH of a 
1% (w/v) solution of CS was adjusted to 8.5 using a 5 M NaOH solution. The methacrylation process 
occurred with the addition of 10-fold excess molar of methacrylic anhydride (276685, Sigma) to 
the CS solution. The pH was adjusted to 8-8.5 for 24h at 4ºC.  Then, the reaction products were 
precipitated by adding 3-fold reaction volume of cold ethanol (absolute ethanol at -20oC, 
E/0650DF/17, Enzymatic). Three subsequent centrifugation steps (6154 g, once for 10 minutes 
and twice for 5 minutes) using absolute ethanol were performed. The met-CS was then dialyzed 
(cellulose dialysis membranes, average flat width 33 mm, Mw cut-off 14 kDa, Sigma) against 
distilled water for one week, with water renewal three times a day. Finally, the solution was filtered 
(180µm, Millipore), frozen at -80oC and freeze-dried (LyoALfa 10/15 Telstar) for one week. 
3.3.3  Production of Methacrylated - Chondroitin sulfate nanoparticles (met-CS 
MNPs) 
3.3.3.1. Production of MNPs by Co-Precipitation method 
MNPs were prepared by co-precipitation of Fe2+ and Fe3+ with ammonium hydroxide (NH4OH) 
(05002, Sigma) as previously described [20]. Briefly, FeCl3.6H2O (31232, Sigma) and FeCl2.4H2O 
(220299, Sigma) were mixed at a molar ratio of 2:1 (2.25 mmol Fe3+: 1.125 mmol Fe2+) under 
magnetic stirring and in a nitrogen environment. The mixture was heated up to 80 oC and 25% (v/v) 
of NH4OH was added to the salt solution until pH 10.5. The solution was further cooled at room 
temperature for 15 min and the precipitate was separated from the solution using a permanent 
magnetic (0.6 T). These particles were washed 3 times with Millipore water and 3 times with 
absolute ethanol by centrifugation at 8322 rcf for 15 min. 
3.3.3.2. Functionalization of MNPs with a met-CS Coating 
A 2% (w/v) met-CS solution was added dropwise to the suspension of uncoated MNPs at a 
solid/liquid ratio of 20 g/L at pH 6.3 ± 0.3 for 24h under magnetic agitation in a nitrogen 
environment. 
The stabilization of the met-CS coating was performed with adipic acid dihydrazide (ADH) (A0638, 
Sigma) using a well-established carbodiimide (EDCI) (424331, Sigma)-based chemistry22. Briefly, 
the met-CS MNPs suspension was set to pH 4.75 and a solution containing an excess molar of 2:1 
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(ADH/EDCI:met-CS) was dropwise added to the suspension. The pH was continuously adjusted to 
4.5 with 0.1 M of HCl until no pH variation was observed. The solution was washed 3 times by 
centrifugation (8322 rcf, 10 min) with Milipore water and dialyzed (cellulose dialysis membranes, 
, Mw cut-off 14 kDa, Sigma) for one week against Milipore water. 
3.3.4  Development of magnetic responsive hydrogels enriched with platelet lysate 
(met-CS MAGPL Hydrogels) 
Photocrosslinkable, met CS hydrogel matrices were produced using the photoinitiator Irgacure 
2959 [2-hydroxy-4’-(2-hydroxyethoxy)-2-methylpropiophenone 98%] (410896, Sigma) in the 
presence of UV light. In brief, Irgacure 2959 (0.25 % (w/v)) was dissolved in either PBS or in a PL 
solution, obtained as described in section 3.3.1., where a 8% (w/v) met-CS was dissolved 
afterwards. The solution was vortex and centrifuged (2 minutes at 6000 rpm). Afterwards, met-CS 
MNPs (100, 200 and 400 µg/mL) were added to the met-CS solution of PBS (met-CS MAG) or PL 
(met-CS MAGPL) and sonicated for 20 seconds. Hydrogels without met-CS MNPs were also 
produced as controls.  
After assessing the most promising hydrogel formulation with met CS MNPs (200µg/mL) for 
cellular studies, PL enriched met CS hydrogels were produced as single and double hydrogel units.  
The single hydrogel units were produced by injecting 50 µL of the solution of met-CS PL with 
Irgacure in a PDMS mold (5mm×5mm) and UV polymerized for 120 seconds 
In the case of double hydrogel units, the first hydrogel unit was prepared as described for the single 
units and placed into the left side of a second PDMS mold (10mm×10mm) and another 50 µL of 
solution was added to the right side of this mold. The hydrogels units were physically attached into 
a double hydrogel unit by UV light polymerization for 120 seconds.  
3.3.5  Characterization of met-CS by 1H Nuclear Magnetic Resonance (NMR) 
The degree of methacrylation (Dm) of CS was determined by the analysis of 1H NMR spectrum. 
met-CS were dissolved in deuterium oxide (2H2O, D-020-100, Laborspirit) at 5mg/mL and their 
spectra recorded (Varian Inova 500) at 70oC with a frequency of 400.13 MHz and a delay of 1s. 
The Dm was calculated based on the ratio between the relative area of the peaks corresponding to 
vinyl protons of methacryloyl moiety (at 5.8 and 6.2 ppm) and the methyl protons of the acetyl 
moiety of CS (at ~2.1 ppm), present in Annex 1.   
3.3.6  Characterization of produced MNPs 
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3.3.6.1Fourier Transform Infrared (FTIR) Spectroscopy 
CS, met-CS, uncoated MNPs and met-CS MNPs samples were mixed with potassium bromide, and 
processed into pellets. The infrared spectra of CS, met-CS, uncoated MNPs and met-CS MNPs 
were record in an IR-Prestige-21 equipment (FTIR Shimadzu). The spectra were obtained in the 
range of 400 to 4000 cm-1 at a 4 cm-1 resolution with 32 scans 
3.3.6.2. Electrokinetic Measurement (Zeta Potential) and Hydrodynamic Size 
The zeta potential of uncoated MNPs and met-CS MNPs was measured at different pH (3, 5, 7, 
10) and the hydrodynamic size was assessed at 7.4., in both cases at room temperature, using a 
ZetaSize Nano-ZS (Malvern Instruments Ltd). 
For that, met-CS MNP and uncoated MNPs solutions (0.005% (w/v)) were prepared in Millipore 
water and the pH adjusted accordingly to the desired pH (3, 5, 7, 10) before being sonicated for 1 
minute at room temperature.  
The mean diameter was evaluated using the Stokes-Einstein equation. Triplicate samples were 
considered and analyzed for a minimum of 10 scans. 
3.3.6.3.Thermo Gravimetric Analysis (TGA) 
The met-CS coating of met CS MNPs was assessed with a simultaneous thermal analyzer (model 
STA7200, Hitachi). Met-CS MNPs (2-4 mg) were placed in a stainless steel crucible and an empty 
stainless steel crucible was used as reference. The sample was exposed to a rising temperature 
up to 105oC (10oC/min) under an oxygen environment. Then, the temperature was isothermally 
held for 10 min, increased to 600oC (20oC/min) and isothermally maintained during 20 min under 
nitrogen environment. The mass was recorded as function of the temperature. The weight 
percentage of met-CS in the MNPs was calculated comparing the mass loss after water removal 
and the remaining mass. Uncoated MNPs were used as experimental controls. Four replicates per 
condition were analyzed.  
3.3.6.4.Magnetic Properties of produced MNPs 
The magnetization measurements of uncoated MNPs and met-CS MNPs were assessed in a 
superconducting quantum interference device (SQUID-VSM) magnetometer from Quantum Design, 
under an applied magnetic field between −20.0 and 20.0 kOe at room temperature. Before the 
analysis, met-CS MNPs and MNPs were freeze dried (LyoALfa 10/15 Telstar) for three days. 
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3.3.6.5.Transmission Electron Microscopy (TEM)  
The size of the uncoated MNPs and met-CS MNPs were assessed by Transmission Elecron 
Microscopy TEM (Jeol JEM 1400, Zeiss model EM 10C), upon preparation of solutions with 0.05% 
of uncoated MNPs and met-CS MNPs in Millipore Water. The Electron Microscopy Service of I3S 
(Instituto de Investigação e Inovação em Saúde) prepared and performed the analysis. 
3.3.7  Characterization of magnetic responsive hydrogels enriched with platelet lysate (met-
CS MAGPL Hydrogels) 
3.3.7.1. Low Temperature Scanning Electron Microscopy (cryo-SEM) and 
Transmission Electron Microscopy 
The microstructure of magnetic hydrogels enriched with PL (met-CS MAGPL) with 200 and 400 
µg/mL of met-CS MNPs (met-CS200 and met-CS400 MAGPL) was assessed by cryo-SEM. 
Hydrogels without MNPs (met-CS and Met-CS PL hydrogels were used as control).  
The Cryo-SEM analysis was performed using a high resolution scanning electron microscope with 
X-ray Microanalysis with a JEOL JSM 6301F/ Oxford INCA Energy 350/ Gatan Alto 2500 
equipment. For that, the hydrogels were rapidly cooled into slush nitrogen and transferred under 
vacuum to the cold stage of the preparation chamber. Further the specimen was fractured, 
sublimated (‘etched’) for 120 sec. at -90°C, and coated with Au/Pd by sputtering for 45 sec. The 
analysis was performed at a temperature of -150°C.  
In order to assess the distribution within the met-CS MAGPL hydrogels transmission electron 
microscopy (Jeol JEM 1400, Zeiss model EM 10C) was performed, using the same equipment 
referred above. In these case the formulations were fixed with a specific fixator for TEM (TEM-Fix) 
and met-CS PL hydrogels as control. 
3.3.7.2. Dynamic Mechanical Analysis 
DMA was used to measure the mechanical/viscoelatic properties of magnetic met-CS hydrogels 
enriched with PL with different concentrations of met-CS MNPs (200, 400 µg/mL) using an 
ATRITEC8000B DMA (Triton Technology, UK) equipped with a compressive mode. Hydrogel 
without met-CS MNPs were used as control. Hydrogels with approximately 5 × 5 mm and a 
thickness of 1 mm were assayed. The experiment was performed by applying compression cycles 
of increasing frequency (0.1-10 Hz) under constant strain amplitude (0.1 µm) using a preload of 
0.1 % of the sample thickness. The assays were performed under simulated physiological 
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conditions by immersion of the samples in a Teflon reservoir with α-MEM medium at 37ºC. At least 
three hydrogels per formulation were tested. 
3.3.7.3. Effect of magnetic stimulation in the properties of developed met-CS 
MAGPL hydrogel 
Magnetic stimulation was provided by a magnefect nano device (nanoTherics Ltd, Keele, UK) under 
an oscillation frequency of 2 Hz and 0.2 mm of displacement conditions composed by an oscillating 
magnet array system (0.35 T per magnet per scaffold). The magnetic stimulation induced by the 
oscillation frequency was maintained without interruption during the experimental setup. Samples 
under static, non-stimulating, conditions were used as experimental negative controls of the 
magnetic actuation influence. 
The influence of an external magnetic field in the swelling and degradation was assessed in 
cylindrical-shaped met-CS200 MAGPL hydrogels (5 mm diameter and 5 mm of height). 
For the swelling assay met-CS200 MAGPL hydrogels were incubated in 1.5 mL of PBS at 37º C, 
collected after 3 and 6 h, 7 and 21 days and weighted in an analytical balance (Denver Instrument, 
Germany) after the removal of excess surface liquid  
In the degradation assay, hydrogels were incubated at 37ºC in 1.5 ml of a solution of 2.6 U/mL of 
hyalurodinase (HAse, H2126, Sigma) in PBS or in PBS alone (experimental control) for 3 and 6 
hours, 1, 4, 7, 10, 13, 17 and 19 days. At each time point, the formulations were weighed using 
an analytical balance (Denver Instrument, Germany) after removal of excess surface liquid. Then, 
the enzymatic solution or PBS was replaced by fresh solutions until the end of the experimental 
setup.  
Samples under static non stimulating conditions were used as experimental controls. The 
experiments were performed using in a minimum of 3 samples per analyzed condition. 
 
3.3.7.3.1. PDGF-BB release upon Magnetic Stimulation 
The release of platelet derived growth factor (PDGF-BB) from hydrogels subjected to EMF 
stimulation and/or enzymatic degradation was assessed by enzyme-linked immunosorbent assay 
(ELISA), accordingly to manufacturer’s instructions (Pepro Trech). For this, met-CS200 MAGPL 
hydrogels were prepared and  incubated in PBS or in a HAse solution at 37ºC, and the PDGF 
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quantified in the incubation media after 15, 45 and 90 minutes, 3 and 6 hours, 1, 2, 4, 7 and 10 
days. The PDGF-BB was quantified using a minimum of 3 samples per condition. 
3.3.8  Isolation, culture and characterization of cells 
Cells used in the present work were isolated from human tissue samples collected under an 
established protocol with Hospital da Prelada (Porto, Portugal). All samples were obtained under 
informed consent, according to the Declaration of Helsinki and the protocols were approved by the 
ethical committee of the Hospital.  
3.3.8.1. Human Tendon Derived Cells (hTDCs) 
Human tendon derived cells (hTDCs) were collected from tendon samples from patients 
undergoing orthopedic reconstructive surgeries. Briefly, samples were washed with DPBS 
containing 10% (v/v) of A/A and surrounding non-tendon tissue was removed. Afterwards, samples 
were minced and digested with a 0.1% (w/v) collagenase type I solution (Z56.LS004196, Sigma) 
during 1 hour at 37oC under agitation (200 rpm). The digested tissue was filtered (100 µm), 
centrifuged (1200 rpm, 5min, 5ºC) and the cellular suspension was expanded in basal medium (α 
MEM supplemented with 10% FBS, 1% A/A and Na2CO3. In all experimental assays, hTDCs were 
used in passage 2 to 4. 
3.3.8.2. Human Adipose Stem Cells (hASCs) and pre osteogenic differentiation 
HASCs were isolated from lipoaspirate samples of female donors as previously described [18].The 
sample was digested with 0.05% (w/v) collagenase type I in PBS under mild agitation during 45min 
at 37oC. Then, the suspension was filtered (100µm, Sigma), centrifuged (2587rpm, 10 minutes) 
and washed with lysis buffer before centrifuged at 2587rpm for 10 min. The cellular suspension 
was expanded in basal medium, cryopreserved and expanded upon needed. Experimental assays 
were performed with hASCs in passage 3 to 5. 
Human ASCs were cultured in standard osteogenic medium for 14 days before being encapsulated 
in the developed met-CS200 MAGPL hydrogel units. The medium was composed of basal medium 
supplemented with osteogenic factors, namely dexamethaxone (10-8 M, Sigma-Aldrich), ascorbic 
acid (50µg/mL; Sigma-Aldrich) and β-glycerophosphate (10mM; Sigma- Aldrich).  
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3.3.9  Assessment of the Cytocompatibility of Developed MNPs in the Presence of 
hASCs 
The influence of met CS MNPs in cells were assessed by culturing hASCs in 24-well tissue culture 
plates at 103/cm2 in α-MEM. After 24 h, the culture medium was replaced with α MEM medium 
containing different concentrations of MNPs (200, 400 µg/mL) cultured for 1, 3 and 7 days and 
characterized for metabolic activity by Alamar Blue (BUF012B, Arium) and for cellular proliferation 
using a dsDNA quantification kit (P7589,Alfagene). Met-CS MNPs were compared to uncoated 
MNPs and to cells cultured in the absence of MNPs. 
3.3.10 Biological assessment of cell laden hydrogel units 
3.3.10.1. Encapsulation of hTDCs and/ or Pre-Ost in the met-CS MAGPL 
hydrogel tendon and bone units 
The behavior of cells laden in met-CS200 MAGPL hydrogels was assessed in single (tendon or bone 
units) and co-cultures of hTDCs and hASCs pre differentiated into osteoblatic like cells (pre-Ost) 
(tendon bone interface units).  
HTDCs and pre-Ost were detached using tripLE Express (126905-028, Alfagene) and counted using 
a hemocytometer. Cells were then centrifuged at 1200rpm for 5 minutes and suspended at a 
density of 2×106 /mL in the solution prepared as described in section 3.3.4. 
In tendon and bone single units, 50 µL of the prepared solution containing hTDCs or pre-Ost was 
injected and polymerized as described in section 3.3.4. In the case of the co-culture systems, 50 
µL of the solution containing hTDCs was injected in the PDMS mold with 5mm×5mm of dimensions 
before UV polymerized for 120 seconds. Then, the formed hydrogel (tendon unit) was placed into 
the left side of a PDMS mold with 10mm×10mm and 50 µL of the prepared solution containing 
pre-Ost cells was added to the right side of 10mm×10mm mold, and produced as mentioned for 
the tendon unit, forming a single co-culture tendon-bone interface unit. Both single and co-culture 
units were gently removed from the mold and cultured in 24 well plate in basal medium during 1, 
7, 14 and 21 days in EMF. Formulations cultured in non-stimulating conditions were used as 
experimental control of magnetic actuation. 
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3.3.11 Characterization Cell Behavior in the Developed Systems 
3.3.11.1. Alamar Blue® assay 
The metabolic activity of hASCs in the presence of uncoated and met-CS MNPs was verified after 
1, 3 and 7 days while cell-laden met-CS MAGPL hydrogels in single and co-culture units was 
assessed at  1, 7, 14 and 21 days. Briefly, Alamar Blue solution (AB, 10 % (V/V)) was prepared in 
α-MEM medium. Samples were washed twice in PBS and incubated with 800 µL of the AB solution 
previously prepared for 5 hours at 37ºC.The fluorescence was read in a microplate reader (Synergy 
HT, BIO-TEK) with an excitation of 530 nm and an emission of 590 nm. At least 3 biological 
replicates were considered for each condition per time point 
3.3.11.2. Cellular Content Assay (dsDNA quantification) 
The cell content of hASCs cultured with different concentrations of met-CS MNPs was assessed 
after 1, 3 and 7 days and after 1, 7, 14, 21 days in single (bone or tendon) and co-culture (tendon-
bone units)  
The samples were washed twice with PBS, 1 mL of ultra-pure water was added and the samples 
were frozen at -80ºC. Prior to the analysis, the samples were thawed and milled in an ultrasonic 
processor (VCX-130PB-220, Sonics). The quantification of dsDNA was performed using a Quant-Ti 
PicoGreen dsDNA Assay Kit (Thermo Fisher Scientific) accordingly with manufacturer´s 
instructions. At least 5 biological replicates were considered for each condition per time point.  
3.3.11.3. Immunolabelling of tendon and bone related proteins:  
Immunolabelling for Collagen I (COLIA1) (ab90395), Osteopontin (OPN) (ab14175) and Tenascin-
C (TEN) (ab6393) was performed in single units after 7 and 21 days and co-culture cell hydrogel 
units after 21 days in culture. All antibodies were purchased to Abcam. The antibodies were diluted 
as 1:200, 1:100 and 1:200 for collagen I, osteopontin and tenascin-C respectively and incubated 
1 hour at room temperature. The fluorescent secondary antibody Alexa Fluor 488 (A21206, 
alfagene) was incubated for 1 hour at room temperature followed by DAPI (4', 6-diamidino-2-
phenylindole) (1:1000, 40009, VWR) and Phalloidin Red (Phalloidin–Tetramethylrhodamine B 
isothiocyanate) (1:200, P1951, Labodidactica) stains. After, the samples were analyzed in an 
inverted confocal microscope (TCS SP8, LEICA) equipped with argon/He-Ne laser sources. 
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3.3.11.4. Gene Expression Analysis by Real-Time Polymerase Chain Reaction (RT-
PCR) 
The expression of the genes COLAI, DCN and TEN was assessed by real-time polymerase chain 
reaction (RT-PCR) on RNA isolated from hTDCs and pre-Ost and co-cultures 7, 14 and 21 days 
after the encapsulation in met-CS MAGPL hydrogels. In tendon-bone units, hydrogels were 
sectioned in three parts: tendon unit: the section with the hydrogel encapsulating hTDCs, the 
interface between the hydrogel encapsulating hTDCs and pre-Ost and the bone unit where pre-Ost 
were laden in the hydrogel. Four independent biological replicates were analyzed for each time 
point. 
Total RNA was isolated from cells laden in the hydrogel using the TRI Reagent® RNA Isolation 
Reagent (733-1089, Sigma-Aldrich) according with the manufacturer’s instructions. The yield and 
purity of RNA isolation was determined by spectrometry using the NanoDrop 1000 
Spectrophotometer (ThermoScientific). The cDNA was synthesized using 100 pg of RNA as 
template and the qScript™ cDNA Synthesis Kit (733-1175, VWR). The primers, listed in Table 3.1 
were designed using the primer-BLAST tool available at 
http://www.ncbi.nlm.nih.gov/tools/primer-blast. Target genes were normalized to the reference 
housekeeping GAPDH gene according to Livak’s method[21]. The analysis was performed on a 
real time Polymerase Chain Reaction (RT-PCR) Mastercycler (Realplex, Eppendorf).  
 
Table 3.1: List of primers used for RT-PCR expression analysis of osteogenic and tendon related 
genes. The primers were designed using the primer-BLAST web tool. 
 
NCBI Reference 
Sequence 
Gene product Gene 
Short 
name 
Primer sequence Product 
length [bp] 
NM 
001040058.1 
Secreted 
phosphoprotein 1 
(Osteopontin) 
SPP1 CAGACCTGACATCCAGTACCC 
GGTCATCCAGCTGACTCGTT 
173 
NM 001920.3 Decorin DCN CAGCATTCCTCAAGGTCTTCC
T 
GAGGCCATTGTCAACAGCA 
154 
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NM 000088.3 Collagen alpha-
1(I) chain 
COLIA1 CCCCAGCCACAAAGAGTCTAC 
TTGGTGGGATGTCTTCGTCT 
150 
NM 
001256799.1 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
GAPDH GGGAGCCAAAAGGGTCATCA 
GCATGGACTGTGGTCATGAGT 
198 
 
3.3.12 Statistical Analysis 
Results are presented as mean ± standard deviation. The statistical analysis of data was performed 
using GraphPad Prism 6 software. Statistical analysis was carried out using 2-way ANOVA for 
significant differences among studied conditions followed by Turkey's multiple comparison test. A 
minimum of 95% confidence interval was considered for all measurements (p<0.05). Statistical 
significant values and associated degree of confidence (p<0.05) are denoted by symbols 
represented in the graphs. 
 
3.4 Results 
3.4.1 Production and Characterization of Uncoated MNPs and Met-CS MNPs 
In this work, iron oxide magnetic nanoparticles (MNPs) were successfully produced by a co-
precipitation method. The developed MNPs were further coated with CS modified with 
methacrylated groups and stabilized via a crosslinking reaction with ADH promoted by 
carbodiimide. These MNPs were further characterized and their physicochemical, morphologic and 
magnetic properties are described below.  
3.4.1.1. Physicochemical characterization of met-CS MNPs 
FTIR analysis of uncoated and met-CS MNPs was performed to confirm the presence of the met-
CS coating (Figure 3.1).  
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Figure 3.1: FTIR transmittance spectra of uncoated magnetic nanoparticles (MNPs, dashed black 
line), chondroitin sulphate (CS, red dashed line), methacrylated chondroitin sulfate (met-CS, red 
line) and MNPs coated with met-CS (met-CS MNPs, black line). Red line corresponds to the 
anhydrous aldehyde (R-C=O) stretch at ~ 1715cm-1. The dashed grey line indicates the amide 
stretch at ~ 1639cm-1 and sulphate group at 1250 cm-1. The black lines matches with to the 
amide (R-C=O-NH-R’) NH vibrational bending at ~1569cm-1 and C=O stretch of the carboxylic group 
at ~1612cm-1. The dashed red lines correspond to the iron III oxide peaks at ~ 570 and 453 cm-1. 
 
The FTIR spectrum of CS (non-methacrylated) displays the typical bands associated with this 
polymer at ca. 1639 and 1416 cm-1, which are assigned to the asymmetric and symmetric axial 
deformations of the carboxylate anion (–COO– stretching) and the peak related to the sulfate group 
at 1250 cm-1 (represented with grey dashed lines). The presence of the methacrylic group on met-
CS was confirmed by the ester absorption peak at 1715 cm-1, which corresponds to pendant vinyl 
groups (–CH=CH2) not detectable  in the CS polymer (red line).  
The iron III oxide absorption bands at 460 and 540 cm-1 were observed in uncoated and met-CS 
MNPs spectra (red dashed lines). The met-CS MNPs spectrum showed the typical bands of met-
CS polymer and of MNPs, confirming the presence of CS polymer in met-CS coated MNPs (met-
CS), which are not observed in the uncoated MNPs spectrum. The successful crosslinking with 
carbodiimide and EDCI to stabilize the met CS coating of met-CS MNPs was detected by the 
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disappearance of the characteristic asymmetric vibration of R-COO- at approximately 1612 cm-1 
and the presence of NH bending from the secondary amide at 1569 cm-1 (black lines). 
Additionally, the weight percentage (wt %) of polymeric coating in the met-CS MNPs was quantified 
by TGA analysis performed under an oxygen atmosphere.  
A5.9 ± 0.25 % wt of organic phase was detected in met-CS MNPs, which corresponds to the 
polymer coating. This value was calculated by subtracting the percentage of weight loss obtained 
for the uncoated MNPs to the value of met-CS present in the met-CS MNPs. 
The stability of met-CS MNPs in aqueous conditions was assessed by measuring the electrokinetic 
potential at different pH and compared to uncoated MNPs (Table 3.2).  
 
Table 3.2: Assessment of Zeta Potential of (A) uncoated MNPs and (B) met-CS MNPs obtained at 
different pH- SD represents the standard deviation.  
 
 
 
 
 
 
 
 
 
 
The electrophoretic mobility of MNPs showed a positive net surface charge at pH up to 7.2, 
necessary to assure the formation of the met-CS coating (negatively charged) (Table 3.2). After the 
coating of MNPs with met-CS, the net surface charge became negative in the range of studied pH 
values. These results indicate that the formation of a colloidal stable suspension of uncoated MNPs 
was only possible at strongly acidic pH or strongly basic pH. At physiological pH, uncoated MNPs 
presented low electrostatic repulsion, which relates to less stable suspensions, while met-CS MNP 
suspensions were more stable. The stability of MNPs in suspension was also confirmed by the 
sedimentation rate at physiological pH (Figure 3.2).  
 
pH Zeta Potential SD 
3 31.57 1.87 
5 22.80 1.22 
6.5 12.07 0.12 
7.2 0.20 0.86 
12 -46.87 4.72 
pH Zeta Potential SD 
3 -8.15 0.41 
5 -21.93 0.73 
7 -26.73 1.03 
10 -31.50 0.20 
A B 
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Figure 3.2: Sedimentation rate of A) Uncoated MNPs; B) met-CS MNPs after 20h in Millipore water 
at pH 7 and room temperature. 
 
 
As observed in Figure 3.2 a suspension of uncoated MNPs (Figure 3.2A) showed a faster 
sedimentation rate than a suspension of met-CS MNPs (Figure 3.2B).  
The hydrodynamic size of met-CS MNPs was measured at pH=7, showing an average size of 210.8 
± 0.225 nm with a polydispersity index (PI) of 0.225 ± 0.009.  
Furthermore, the dimensions and shape of developed MNPs was also assessed by TEM (Figure 
3.3). 
 
 
 
Figure 3.3: Assessment of MNP dimensions. TEM images of A) Uncoated MNPs and B) met-CS 
MNPs. The scale bar represents 50 um. 
 
A B 
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TEM images showed that the produced MNPs have a typical round-shape morphology and an 
average diameter of 6.9 ± 1.0 nm that is not affected by the presence of a met CS coating.  
3.4.1.2. Magnetic characterization of met-CS MNPs 
Magnetic properties of met-CS MNPs were evaluated using a SQUID-VSM magnetometer and are 
represented in the Figure 3.4. 
 
 
 
Figure 3.4: Hysteresis loop of A) Uncoated MNPs b) Met-CS MNPs under an applied magnetic field 
between −20.0 and 20.0 kOe at room temperature. 
 
The absence of remaniscence and coercive forces at zero magnetic field confirms the 
superparamagnetic behaviour of MNPs at room temperature. The magnetic saturation values were 
found to be 68.12 emu/g for uncoated MNPs and 60.66 emu/g for met-CS MNPs. The magnetic 
saturation values of met-CS MNPs were then normalized with the weight percentage of met CS 
coating (5.9 ± 0.25 %) determined by TGA, showing no loss of magnetic saturation with the coating 
process. 
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3.4.1.3. Cytocompatibility assessment of developed MNPs 
 
To incorporate met-CS MNPs into 3D constructs aiming at TE approaches, the evaluation of their 
cytocompatibility is of critical importance. Thus, the effect of the concentration of MNPs on the 
viability and proliferation of human adipose derived stem cells (hASCs) was followed-up for 7 days 
(Figure 3.5). 
 
Figure 3.5: Metabolic activity of hASCs cultured in the presence of different concentrations of MNPs 
(0, 200, 400 µg/mL) after 1, 3 and 7 days in basal culture medium. a) Uncoated MNPs and b) 
Met-CS MNPs. Symbol (*) denote statistically significant differences (p<0.05). 
 
The profile of the metabolic activity of hASCs cultured in the presence of MNPs was similar in both 
uncoated MNPs and met CS MNPs with a tendency to increase with the time in culture, suggesting 
that the presence of MNPs does not negatively affect the viability of these cells. However, hASCs 
cultured in the presence of uncoated MNPs and metCS MNPs show lower metabolic activity after 
3 days of culture in comparison with cells cultured without MNPs (p<0.05). However, after 7 days, 
only the highest concentration of met CS MNPs (400 µg/mL) resulted in a lower metabolic activity 
in comparison to cells cultured without MNPs (p<0.05). 
Furthermore, the quantification of dsDNA of cells in the presence of MNPs supports the results of 
metabolic activity (Figure 3.6).  
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Figure 3.6:  Cellular Content quantification of hASCs cultured in the presence of different 
concentrations of MNPs (0, 200, 400 µg/mL) after 1, 3 and 7 days in basal culture medium. a) 
Uncoated MNPs and b) Met-CS MNPs. Symbol (*) denote statistically significant differences 
(p<0.05). 
 
An increase of cell content was observed in the presence of both uncoated MNPs and met-CS 
MNPs over the time in culture (Figure 3.6). A decrease of DNA content of hASCs cultured for 3 in 
the presence of metCS MNPs and for 7 days in the presence of uncoated MNPs when comparing 
to hASCs cultured in the absence of MNPs (0 µg/mL). In the case of metCS, this decrease in cell 
content is overcome at 7 days when dsDNA values are similar to the ones from hASCs without 
MNPs. 
3.4.2 Production and Characterization of Methacrylated Chondroitin Sulfate Magnetic 
Hydrogels Enriched with Platelet Lysate (met-CS MAGPL hydrogels) 
After the production and characterization of met-CS MNPs, they were further incorporated into 
photocrosslinkable met-CS MAG hydrogels enriched with PL. The met-CS MAGPL hydrogels were 
produced with different concentrations of met-CS MNPs, namely0, 200 and 400 µg/mL (Figure 
3.7). 
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 .  
Figure 3. 7:  Macroscopic images of the hydrogels produced A) met-CS PL hydrogel; B) met-CS200 
MAGPL hydrogel and; C) met-CS400 MAGPL hydrogel. 
 
The increase in the metCS MNPs concentration incorporated in the hydrogels is detected by a 
darker color of the met-CS MAGPL hydrogel. Overall, no macroscopic aggregates of MNPs were 
detected in the formulations assessed. 
To confirm the crosslinking of met-CS MNPs to the met-CS hydrogel matrix, hydrogels with 2% 
(w/v) of met-CS containing 400 µg/mL of either uncoated or met-CS MNPs were incubated with 
osmotized water (10mM NaCl) at pH 8 and placed in contact with a magnet. Hydrogels produced 
with both types of MNPs were responsive to the application of a magnetic field. The release of 
MNPs was observed from hydrogels incorporating uncoated MNPs, unlike the met-CS MNPs 
incorporated within met-CS MAGPL hydrogels, which remained entrapped in the hydrogel matrix 
(data not shown).  
3.4.2.1. Morphological Characterization of Met-CS MAGPL Hydrogels 
The distribution of met-CS MNPs and their influence in the arrangement of magnetic met-CS 
MAGPL hydrogel microstructure were assessed by TEM (Figure 3.8) and cryo-SEM (Figure 3.9).   
 
5 mm
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Figure 3.8: TEM images of A) met-CS PL Hydrogel B) met-CS200 MAGPL Hydrogel. The scale bar 
represents 100µm 
 
TEM micrographs of met-CS200 MAGPL hydrogel matrices showed spherical met-CS MNPs randomly 
organized in aggregates within the met CS MAGPL hydrogel matrix.  
The CryoSEM micrographs of the met-CS, met-CS with PLs and met-MAGPL hydrogel formulations 
(200 and 400µg/ml of metCS MNPs) are shown in Figure 3.9 A, B,C and D respectively. 
 
 
Figure 3.9: Cross-section cryo-SEM images of A) met-CS; B) met-CS PL; C) met-CS200 MAGPL; C) 
met-CS400 MAGPL. The scale bar represents in the images of the left 30 µm and the right 6 µm. 
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Significant differences were observed in the microstructure of the developed hydrogels in terms of 
micropore dimensions, interconnectivity and micropore distribution within the matrix. Met CS Mag 
hydrogel presented a condensed matrix with smaller pores homogeneously distributed within the 
matrix. The PL enrichment to the matrix change the morphology of the hydrogel matrix creating a 
homogenous distribution of trabecular structures (not present in met-CS MAG hydrogels) containing 
smaller pores with similar dimensions and shape to the ones observed in met CS hydrogels. The 
incorporation of met CS MNPs within the hydrogels also influenced the morphology of the matrix, 
reducing the dimensions of the trabecular structures observed in PL enriched hydrogels. This 
morphological modification seems to be related to the concentration of met CS MNPs incorporated 
in the matrix. Hydrogels with met-CS MNPs200 exhibited a homogeneous distribution of small pores 
randomly dispersed within the larger traberculi-like structures. The metCS MNPs400 formulation 
showed a more random microstructure characterized by the presence of regions with larger pores, 
similar to those observed in the met-CS MNPs200 formulation interspersed with small pores matrix.  
3.4.2.2. Mechanical Characterization of met-CS MAGPL Hydrogels 
The mechanical/viscoelastic properties of met-CS PL and met-CS MAGPL hydrogels (200, 
400µg/mL) were analysed by dynamic mechanical analysis at simulated physiological conditions. 
(Figure 3.10).  
 
Figure 3.10: Storage modulus (E´) and loss factor (tan δ) of met-CS MAGPL hydrogels produced 
with different concentrations of met-CS MNPs (0, 200, 400 µg/mL).  
 
The incorporation of met-CS MNPs into the hydrogel matrix led to an increase in the values of 
storage modulus (E´) in comparison with the hydrogels without met-CS MNPs (p<0.05). The 
increment in the MNP concentration from 200 to 400 µg/ml does not influence the values of 
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storage modulus of the hydrogels (p>0.05). The values of E´ were 41 KPa in the case of met-CS 
PL hydrogels and in met-CS MAGPL hydrogels ranged from 48 to 54 kPa.   
The tan δ  provides information about the damping properties of the produced material and shows 
that hydrogels independently of the presence of met-CS MNPs, presented tan δ values ranging 
between 0.049 to 0.07 that are an indication of the high elastic properties and low energy 
dissipation potential of the produced materials. The presence of met-CS MNPs did not affect the 
tan δ values (p>0.05) of the produced hydrogels. 
The hydrogel formulation with 200 µg/mL met-CS MNPs (met-CS200 MAGPL hydrogel) showed the 
most promising outcomes considering the results obtained from the MNPs characterization 
including those concerning the metabolic activity and DNA content of hASCs cultured with different 
concentrations of met-CS MNPs and from the met-CS MAGPL hydrogel characterization, namely 
DMA analysis, Cryo-SEM and therefeore this formulation was selected for further studies. 
3.4.2.3. Influence of Magnetic field in the Swelling and Degradation Profiles  
The swelling properties of the met-CS200 MAGPL hydrogels as a function of the incubation time were 
monitored in PBS at 37oC (Figure 3.11).  
 
Figure 3.11: Swelling profile of metCS200 MAGPL Hydrogels in PBS at 37ºC for 21 days 
 
Overall, the swelling ratio, which correlates to the time of liquid immersion, presented a maximum 
mass increase of 2156 ± 32.8 %. Afterwards, the hydrogel swelling remained almost unaltereted 
during the experimental setup (21 days).  
 
The impact of magnetic field in the weight loss profile of the hydrogel was assessed as a function 
of incubation time in the presence/absence of an enzymatic solution of HAse (Figure 3.12).  
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Figure 3.12: Weight loss profile of met-CS200 MAGPL hydrogels in a solution of 2.6U/mL 
hyaluronidase and under the application of an external magnetic field (EMF) in PBS at 37ºC for up 
to 20 days. Continuous black line and grey line represents respectively under EMF , with HAse and 
without  EMF with HAse. Dashed black line represent with EMF without HAse and dashed grey line 
represents without EMF without HAse. 
 
Herein, met-CS200 MAGPL hydrogels incubated under the actuation of an external magnetic field 
(EMF) reached the maximum sweeling ratio after 1 day of incubation (Figure 3.12).  
Hydrogels cultured in static conditions (without EMF) the maximum swelling was acchieved by day 
3. The integrity of hydrogels incubated in PBS was mantained during the experimental setup.  
Moreover, the impact of magnetic field and the influence of hyalurodinase (HAase) in the 
degradation of the hydrogel profile were also assessed as a function of incubation time (Figure 
3.12).  
Met-CS200 MAGPL hydrogels incubated in the presence of HAse under EMF stimulation degraded 
faster than the formulation in static conditions with HAse. In the presence of EMF stimulation and 
enzymatic solution the degradation was complete after 17 days. In the absence of EMF and in the 
presence of HAse, hydrogels reaching a complete degradation after 19 days.   
3.4.2.4. Influence of Magnetic field in GF release of met-CS MAGPL hydrogel 
The release profile of PDGF-BB from met-CS200 MAGPL hydrogels under the presence/ absence of 
magnetic stimulation and in the presence/absence of HAse during 10 days is represented in Figure 
3.13. 
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Figure 3.13: ELISA quantification of PDGF-BB release from met-CS200 MAGPL hydrogels to a 
solution of 2.6U/mL hyaluronidase under the application of an external magnetic field (EMF) in 
PBS at 37ºC for up to 10 days. Continuous black line and grey line represents respectively under 
EMF , with HAse and without  EMF with HAse. Dashed black line represent with EMF without HAse 
and dashed grey line represents without EMF without HAse. 
 
Independently of the presence/absence of magnetic stimulation and HAse solution, the release of 
PDGF-BB was caracterized by an initial burst. In the absence of HAse the release of PDGF-BB 
followed a sustained delivery up to 10 days. Moreover, the presence of magnetic field led to an 
aparent increase in the release of PDFG-BB in the absence of HAse as early as 2 days of incubation. 
Independently of the EMF, in the presence of HAse, the release was continuously increased, being 
once again apparently higher under EMF stimulation in comparison with the formulation without 
EMF. 
3.4.3 Biological assessment of cell-laden hydrogel systems 
To assess the ability of developed metCS200 MAGPL hydrogels to act as a cell carrier for tendon bone 
interface strategies, (hTDCs) and hASCs pre-differentiated into osteoblast-like cells (pre-Ost) were 
laden in the met-CS MAGPL hydrogels, either in single hydrogel units or as double hydrogel units, 
co-culturing hTDCs and pre-Ost under magnetic stimulation.  
3.4.3.1. Metabolic Activity and Cellular content 
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The metabolic activity and cellular content of cells laden in metCS200 MAGPL hydrogels were 
assessed in single  units as well as in the co-culture system after 1, 7,14 and 21 days (Figure 3.14 
and 3.15).  
 
Figure 3.14: Metabolic activity of cell encapsulated in the metCS200 MAGPL hydrogel in the presence 
(with EMF) or absence (without EMF) of magnetic stimulation. A) Human tendon derived cells 
(hTDCs); B) hASCs pre differentiated into osteoblastic like cells; C) Co-culture of hTDCs and hASCs 
pre differentiated into osteoblastic like cells encapsulated in the met-CS200 MAGPL hydrogels. 
Symbols (*) denote statistically significant differences (p<0.05). 
 
 
HTDCs and pre-Ost encapsulated in single or double hydrogel units maintained metabolic activity 
with the time in culture and were not afected by the actuation of an external magnetic field 
(p<0.05). 
The results of dsDNA quantification for cells laden in metCS200 MAGPL hydrogels are indicated in 
Figure 3.15. 
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Figure 3.15: dsDNA content of cell encapsulated in the metCS200 MAGPL hydrogel in the absence 
(without EMF) and under magnetic (with EMF) conditions. A) Human tendon derived cells (hTDCs); 
B) hASCs pre differentiated into osteoblastic like cells; C) Co-culture of hTDCs and hASCs pre 
differentiated into osteoblastic like cells encapsulated in the met-CS200 MAGPL hydrogels. Symbols 
(*) denote statistically significant differences (p<0.05). 
 
HTDCs and pre-Ost cells laden in met-CS MAGPL hydrogels evidenced a significant decrease in 
cell content from day 1 to day 7 (p<0.05), independently of the EMF stimulation or if they are 
cultured in single or co-culture units. Beyond day 7, cellular content values were kept stable and 
are maintained during the experimental setup, without significant variations up to 21 days 
(p>0.05).  
Overall the results showed that the actuation of an EMF does not negatively influence cell viability 
and proliferation, in comparison to non-magnetic stimulation.  
3.4.2.2. The Role of Magnetic Stimulation in tendon-to-bone interfacial units 
The morphology and distribution of cells laden  in met-CS200 MAGPL hydrogels were evaluated by 
confocal microscopy as well as the the presence and organization of ECM proteins namely 
Tenascin-C (TEN) (Figure 3.16), collagen I (COLAI) (Figure 3.17 and 3.18),) and osteopontin (OPN) 
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(Figure 3.19). Single and double hydrogel units were investigated in the presence or absence of 
magnetic stimulation.  
 
 
Figure 3.16: Tenascin-C immunolocation in hTDCs laden in met-CS200 MAGPL hydrogels, cultured 
for 7 and 21 days under EMF or static culture (non-EMF). DAPI (blue) stains cell nucleus; Phaloidin 
(red) represents F-actin and Tenascin-C is represented in green. Scale bar represents 100 μm. 
 
After 7 days ofculture, tendon units exhibited hTDCs both at the surface and in the inner sections 
of the hydrogel. Human TDCs exhibited a fusiform fibrobastic-like morphology at the surface of the 
hydrogels in static conditions. Moreover, at the surface of the hydrogel, the actuation of an EMF 
seems to favor a round morphology of the laden cells with the time in culture. 
The presence on Tenascin C is mildly detected as ealy as 7 days in culture, especially at the surface 
of the hydrogel, independently of the magnetic stimulation (Figure 3.16) Nevertheless, Tenascin C 
was also observed inside the hydrogel, especially after 21 days under EMF. Also by 21 days, the 
presence of tenascin-C was highly pronounced at the surface of hydrogels cultured in non EMF 
conditions. (Figure 3.16).  
The collagen I was also assessed in hTDCs laden in metCS200 MAGPL hydrogels (Figure 3.17) 
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Figure 3.17:  Collagen I immunolocation in hTDCs laden in met-CS200 MAGPL hydrogels, cultured 
for 7 and 21 days under EMF or in static culture (non-EMF). DAPI (blue) stains cell nucleus; 
Phaloidin (red) represents the cell cytoskeleton and collagen type I is identified in green. Scale bar 
represents 100 μm. 
 
The presence of Collagen I was mildly detected by hTDCs in non-EMF conditions at day 7 and 
apparently was not found under EMF stimulation (Figure 317). By 21 days, the increment in the 
amount of collagen I detected was evident, especially at the surface of the hydrogel under static 
conditions. Although at a minor extent, collagen I was detected inside the hydrogel and tended to 
increase over the time in culture (Figure 3.17).  
In the case of pre-Ost cells laden in single units, the fusiform morphology is also observed at the 
surface of the single units (Figure 3.18). 
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Figure 3.18: Collagen I immunolocation in pre-Ost laden in met-CS200 MAGPL hydrogels, cultured 
for 7 and 21 d under EMF or static culture (non-EMF). DAPI (blue) stains cell nucleus; Phaloidin 
(red) represents cytoskeleton and Collagen I is represented in green. Scale bar represents 100 
μm.  
 
Although the colonization of the surface of the hydrogel by pre-Ost cells is considerably higher in 
comparison to hTDCs after 7 days, a cell monolayer covering a significant area of the hydrogel 
surface was observed in both types of cells after 21 days in non-EMF cultures. Also, the cross 
section image shows a thick cell layer covering the surface of the hydrogel. However, under 
magnetic stimulation, cells tended to be preferencially round shaped as occurs with hTDCs, both 
at the surface and inside the hydrogel. A few fusiform cells are also observed at the surface of the 
hydrogels under EMF although in less extent than the ones cultured in static conditions. 
Interestingly, it is the detection of cluster-like structures after 21 days in culture by pre-ost cells.  
After 7 days of culture, it was possible to detect the presence of collagen I at the surface of the 
hydrogel in both EMF and non-EMF conditions, that becomes more evident by day 21 in static 
cultures. Within the hydrogels, the  presence of  of collagen I is residual . 
As for hTDCs, EMF does not seem to promote the colonization of cells at the surface of the 
hydrogels for longer periods of culture. 
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The presence of osteopontin was also assessed in pre-Ost cells laden in developed hydrogels 
(Figure 3.19). 
 
Figure 3.19: Osteopontin immunolocation in pre-Ost laden in met-CS200 MAGPL hydrogels, cultured 
for 7 and 21 d under EMF or static culture. DAPI (blue) stains cell nucleus; Phaloidin (red) 
represents F-actin and Osteopontin represents the tendon ECM protein. Scale bar represents 100 
μm. 
 
Considering the outcomes of cell morphology and protein expression observed in single unit 
cultures, we investigated the morphology of hTDCs and pre-Ost as well as their ability to synthethize 
ECM in co-culture systems 21 days after encapsulation in a double hydrogel unit (Figure 20-22). 
In the co-culture system, a single unit was laden with hTDCs and another with pre-Ost cells and 
the two units physycally assembled by a second polymerization process.  
Matrix deposition and distribution was assessed in different areas of each hydrogel: namely the 
tendon zone, the interface between the tendon zone and bone zone, where the hydrogel units 
combine and finally the bone part as represented in Figure 3.1.  
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Figure 3.20: Collagen I immunolocation in co-culture met-CS200 MAGPL hydrogels, cultured for 21 
day A) static culture or B) under EMF. DAPI (blue) stains cell nucleus; Phaloidin (red) stains 
cytoskeletum Collagen I represents the tendon ECM protein. Scale bar represents 100 μm. 
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In the particular case of the collagen I, this protein seems to be present in hight amounts at the 
surface of the co-culture systems in non-EMF conditions and cells exhibit a fusiform morphology. 
Similarly to cells cultured in single units, co-cultured cells displayed a rounded morphology within 
the hydrogel independently of the hydrogel zone and EMF stimulation. 
When Tenascin C was investigated, the results obtained were different both in terms of morphology 
and protein detection(Figure 3.21) 
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Figure 3.21: Tenascin-C immunolocation in co-culture met-CS200 MAGPL hydrogels, cultured for 21 
d under EMF or static culture. DAPI (blue) stains cell nucleus; and Tenascin-C represents the 
tendon ECM protein. Scale bar represents 100 μm. 
 
In both EMF and non-EMF conditions, cells are considerably abundant at the suface of the hydrogel 
independently of the zone with a  fusiform fibrobastic-like morphology and a high amount of of 
tenascinC was detected. In the inner sections of the hydrogel, the presence of tenascinc is 
favourably influenced by the EMF. Once again the formation of cluster like organization in the 
“bone” unit of the system is observed and that are similar in shape and dimensions to the clusters 
observed in pre-Ost single units under magnetic stimulation (Figure 3.21). 
The immunolabeling of osteopontin was also assessed in the co-culture systems (Figure 3.22) 
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Figure 3.22: Osteopontin immunolocation in co-culture met-CS200 MAGPL hydrogels, cultured for 
21 d under EMF or static culture. DAPI (blue) stains cell nucleus; and Osteopontin represents the 
osteo ECM protein. Scale bar represents 100 μm. 
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OPN, a bone related protein, seems to be present in higher amount in the interface and bone zones 
of the hydrogel, especially at the surface, although is also detected in the inner sections. 
Independently of the EMF, cells tend to be fusiform at the surface of the hydrogel. 
Overall, non-magnetic condition seems to benefits the fusiform morphology of both cell types. The 
actuation of a EMF seems to influence hTDCs and pre-osteoblast like cells into a rounder shape 
after 21 days in culture, and stimulate the formation of clusters in hASCs cells.                          
The co-culture system evidenced a good cell colonization in all zones of the double hydrogel unit,). 
Moreover, cells were able to produce ECM, being possible to detect the presence of characteristic 
proteins , namely collagen I, tenascin C and osteopontin on the surface of the hydrogels resulting 
in a exuberant layer of cells and matrix in both EMF and non-EMF conditions. Also the presence  of 
these proteins seems to be higher in their specific part of the hydrogel. Therefore, in both conditions 
tended to form tissue like matrix at the surface construct. 
3 Gene expression of Tendon and bone Markers 
The expression of bone and tendon markers, namely Decorin (DCN), Osteopontin (OPN) and 
Colagen type I (COLIA1) in hTDCS and/or pre-Ost encapsulated in met-CS200 MAGPL hydrogels 
under static or EMF conditions was evaluated after 7, 14 and 21 days by quantitative RT-PCR 
assay.  The gene expression of the target genes, normalized to the reference housekeeping GAPDH 
gene according to Livack’s method [21], are represented in Figure 3.23 and 3.24.  
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Figure 3.23: Expression of tendon and bone genes in the single units after 7, 14 and 21 days by 
RT- PCR. Symbols (*) denote statistically significant differences (p<0.05). Collagen AI (COLIA1); 
Decorin (DCN), Osteopontin (OPN). 
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Figure 3.24: Expression of tendon and bone genes in the co-culture system after 7,14 and 21 days 
by RT-PCR. Collagen AI (COLIA1); Decorin (DCN), Osteopontin (OPN). 
 
The expression of the tendon marker DCN in hTDCs laden single units was enhanced over time 
independently of the the magnetic stimulation (p<0.05) although EMF presented higher expression 
values (p>0.05). However, while cells under magnetic stimulation reached an DCN gene expression 
10 fold higher after 21 days in comparison of to cells of the day 0, cells that were not exposed to 
EMF after the same culture period expressed DCN in same range of values of the day 0.  The 
expression of the other genes assessed, namely osteopontin and colagen type I showed no 
significant variations with the time of culture nor with the EMF stimulation (p>0.05). 
Regarding the pre-ost cells incorporated in the hydrogels, despite the tendency to increase the 
expression of OPN with the time in culture, the gene expression was maintained independently of 
the EMF conditions. The expression of the other genes assessed, namely decorin and colagen type 
I showed no significant variations with the time of culture nor with the EMF stimulation (p>0.05). 
The gene expression was also evaluated in a co-culture system intended to simulate a tendon-bone 
junction, therefore composed by the combination of: a) the afore evaluated pre-osteoblast-laden 
hydrogel (“bone” side) and the d) TDCs-laden hydrogel (“tendon” side). The expression of the 
genes analysed were not altered in both conditions and were stable during the experimental setup 
(Figure 3.24).  
3.5 Discussion 
Envisioning the unfulfilled need for tissue engineered constructs with improved functionalities, 
meeting the requirements of complex tissues and/or tissue interfaces, we proposed the 
development of a magnetic responsive hydrogel made of a methacrylated chondroitin sulfate- 
matrix enriched with platelet lysate. To render magnetic responsiveness, magnetic nanoparticles 
(MNPs) coated with met-CS  were used to permit the integration of these MNPs within the hydrogel 
matrix, thus allowing the tunability and remote control of hydrogel properties upon implantation 
under the actuation of an external magnetic field (EMF). These properties include the release of 
growth factors  naturally available in PL[22], the degradation rate and the swelling profile of the 
met CS hydrogel which may be manipulated in a precise manner when controlled magnetic forces 
are applied. In addition, the magnetic field can also be used to modulate the behavior of cells, once 
magnetic stimulus has been reported to impact biologic processes by itself or by the activation of 
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MNPs incorporated within an hydrogel matrix[9]. In both situations, the magnetic field can induce 
a cellular response likely by the recapitulation of the mechanical forces required for healthy 
mechano-sensitive tissues such as tendon and bone[9]. Moreover, the inclusion of PL within the 
met CS hydrogel matrix may also mimic the microenvironment that occurs during the process of 
tissue healing once PL is constituted by a pool of mitogenic and bioactive molecules, known to 
modulate tissue repair during tissue injury[17].  
This versatile system can be of particular interest for interfaces tissues, highly prone to injury as 
tendon-to-bone interface[23]. Due to the limited knowledge on this interface, including the cell to 
cell communication from different tissues, cell-microenvironment interactions and the complexity 
of gradients in composition and structure, the challenge stands for recreating this structure  in a 
functional interface-like substitute[24].  
Based on that in the first part of this work, met-CS MNPs were produced through a co-precipitation 
method and further coated with met-CS, followed by a chemical stabilization of the met-CS coating. 
The functionalization of MNPs with methacrilic groups, confirmed by FTIR, is of utmost importance 
when envisioning the incorporation of magnetic nanoparticles into matrices, as the presence of 
methacrylate groups available in the met-CS coating enables the linkage to the matrix through 
photopolymerization[20].  
The crosslinking of the coating with ADH, confirmed by FTIR, allowed the stabilization of the met-
CS coating that permit the direct binding to the surface of MNPs which otherwise would be leached 
from the MNPs surface and could overcome the lack of  functional groups in natural polymers[20]. 
Furthermore, the negative charge (-26.8 ± 1.03 mV)  of the met-CS coating produced MNPs at 
physiological conditions, is consistent with the anionic character of the met-CS polymer which is 
associated to the carboxylic and sulfate groups present in this polymer[25]. As an additional 
advantage, the met-CS coating may prevent the agglomeration of met-CS MNPs in suspension, as 
confirmed by the electrokinetic measurements and by the dispersitivy at physiological pH in 
comparison with the uncoated MNPs. 
Another important feature of the developed MNPs is their intrinsic superparamagnetic behaviour 
at room temperature, with values of magnetization of saturation in the range of 68.12 and 60.66 
emu/g for uncoated MNPs and met-CS MNPs, respectively, that are in accordance in which the 
literature reports for SPIONs magnetization values [20].  This behaviour  allows their application as 
an on/off mechanism, i.e., upon the actuation/removal of magnetic stimulation [20]. 
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Envisioning the use of met CS MNPs to be incorporated into more complex 3D systems as hydrogel 
matrices in biomedical applications, the biological performance of the produced met-CS MNPs was 
investigated as a first screening of cytocompatibility. For this purpose, hASCs were seeded and 
cultured in the presence of uncoated and met-CS MNPs (200 and 400 µg/mL) for 1, 3 and 7 days. 
Although uncoated and met-CS MNPs is affected the metabolic activity and proliferation of the cells 
at a concentration of 400 µg/mL, overall MNPs seem not to negatively influence the viability of the 
cells. In fact, this is in accordance with several studies that have reported the use of iron-based 
particles for tissue engineering namely cell sheets[11], or cell labeling aiming at bone and 
chondrogenic differentiation, without particularly affecting cell viability or functionality up to 400 
µg/mL. Moreover, several studies have reported that iron oxide MNPs are among the safest 
particles to grant magnetic responsiveness to biomaterials, with no measurable harmful effect on 
cell viability [26].  
In brief, the MNPs were successfully produced and the functionalization of these MNP with met CS 
was also successfully achieved. Moreover, the developed met-CS MNP were shown to exhibit 
promising features, namely stability in aqueous suspensions at physiologic conditions, 
superparamagnetic behaviour, and high values of Ms and do not affect the viability and proliferation 
of hASCs etc.  
The functionalized met-CS MNPs were therefore subsequently incorporated into a more complex 
3D system, a met-CS matrix to develop a versatile magnetic responsive hydrogel enriched with PL 
by a photopolymerization process in the presence of a photoinitiator. The importance of CS as 
backbone of ECM is well-known[27] as well as its role in the inflammatory process[28]. Due to its 
strong negative charge, CS establishes electrostatic interactions with positively charged molecules, 
such as GFs available at the PL enriched met CS hydrogel matrix, being further released in a 
controlled manner with the activation of the met-CS MNPs incorporated in the matrix under EMF 
actuation[29]. 
The incorporation of MNPs displaying methacrylate moieties allowed the stabilization of the MNPs 
in the matrix of the hydrogel, an issue that is normally one of the biggest concerns of these 
systems[30] . Therefore, at pH 8, and unlike uncoated MNPs, the met-CS MNPs were not released 
from the matrix because they were bonded to it. In fact that was observed into 2% (w/v) met-CS 
hydrogels incorporating 400 µg/mL of uncoated MNPs at pH 8, released MNPs after contacting 
with a permanent magnetic field, which was not observed in hydrogels incorporating 400 µg/mL 
of met-CS MNPs. This is explained by the fact that, at pH=8 both the uncoated MNPs and the met-
Chapter III: Magnetic Responsive Hydrogels to Engineer Tendon-to-Bone Interfaces 
 109 
 
CS MNPs were negatively charged and the electrostatic interactions that could occur between the 
MNPs and the CS matrix would disappear (see table 3.1). At pH 8, the only factor avoiding the 
release of nanoparticles from the hydrogels incorporating met-CS MNPs was their linkage to the 
matrix.  
Moreover, met-CS MNPs incorporated in met-CS MAGPL hydrogels were showed to be distributed 
in small aggregates. This spatial rearrangement of the MNPs within the met CS matrix is in 
accordance to studies published with magnetic hydrogels produced by the blending method 
highlighting the challenge of having an uniform MNP distribution within the hydrogels that is mainly 
affected by the high viscosity of the hydrogel precursor solution[3]. 
In this study the incorporation of met-CS MNPs and PL within the met CS matrices led to alterations 
in the microstructure and mechanical reinforcement of the hydrogel matrices. Met-CS hydrogels 
presented a homogenous condensed porous matrix that is associated to the structure of the 
polymeric met-CS matrix. Although this condensed porous matrix was also observed in PL enriched 
hydrogels, with the incorporation of PL, larger trabecular like structures were detected and 
integrated with the met-CS matrix that filled the interior of these structures. The presence of these 
larger trabecular like structures interconnected with the smaller pores may relate to the presence 
of structural proteins such as fibrin or vitronectin from PL that have the capacity to form networks 
and also to interact with glycosaminoglycan for the ECM formation during wound healing [31].  
The incorporation of MNPs within the met CS matrix generated hydrogels with a more 
heterogeneous polymeric matrix, exhibiting areas with a microstructure similar to that observed for 
PL-enriched hydrogels and other regions where the polymeric matrix was more loosely organized 
and more evident in hydrogels with higher amounts of MNPs being probably formed by the MNP 
agglomerates shown by TEM images. 
The dynamic mechanical analysis of the hydrogels indicated an increase in the storage modulus 
(E´) in the formulation containing met-CS MNPs that can be attributed to the presence of the met-
CS MNPs bonded to the hydrogel matrix. A similar behavior was observed in other hydrogel 
matrices as the carboxymethylcellulose hydrogels that upon the incorporation of iron magnetic 
nanoparticles in concentrations of 0.5g of nanoparticles per gram of polymer demonstrated an 
increase in the storage modulus in rheometer analysis[32],[30]. Therefore, the iron core of MNPs 
behaves as an elastic material, which leads to an equivalent increase in the storage modulus as 
well as the energy dissipating potential, thus maintaining the range of values of tan δ of the 
formulations without nanoparticles. The low values of the loss factor of the hydrogel matrices are 
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indicative of the high elastic properties of these hydrogels suggesting a low energy dissipating 
potential. Overall the produced met CS hydrogels, independently of the presence of MNPs, 
displayed mechanical properties within the range of other hydrogel systems applied for tissue 
engineering including tendon regeneration and cartilage [33],[34].  
Considering all the results obtained for MNPs including the biocompatibility assay, and metCS 
hydrogel matrix, the concentration of 200 µg/mL met-CS MNPs was chosen (met200 MAGPL 
hydrogels) for further engineering a magneto-responsive hydrogel with tunable features. 
In order to understand the response of the hydrogel, in terms of degradation and swelling profile 
as well as if these properties can be remotely controlled by the application of an EMF, met200 MAGPL 
hydrogels were incubated under magnetic stimulation with 2.6 U/mg of HAse solution. HAse is 
one of the enzymes responsible for the in vivo degradation of CS [35], available at physiological 
concentrations ranging from 0.0059 U/mL in human plasma to 38.5 U/mL in human ovaries. 
Moreover it is present in plasma at concentrations of 2.6 U/mL[36]. The degradation of met-CS200 
MAGPL hydrogel was completed in at least 17 days in the presence of HAse. In addition within this 
study, it was possible to confirm that the presence of magnetic field enhances the enzymatic 
degradation of the hydrogels. Studies on the CS degradation showed a complete degradation after 
one a two days in works with 0.02 U enzyme/mg of CS [37], thus suggesting that the incorporation 
of PL assisted the integrity of the hydrogel matrix. The influence of PL may be related to the 
presence of structural proteins that are not degraded by HAse.  
Moreover, the stimulation of met-CS MNPs integrated in the matrix by EMF is likely to cause a 
temporary cyclic destabilization of the matrix, increasing the permeability of the matrix and 
consequently the capacity of HAse penetration as well as the diffusion of the aqueous solution into 
the hydrogel. This hypothesis is supported by the time frame necessary to hydrogels incubated 
without an enzymatic solution to reach the swelling equilibrium under magnetic stimulation. In fact 
the time that is needed to achieve the maximum swelling was lower in the case of EMF stimulation 
without affecting the integrity of the system.  
Since the developed magnetic responsive hydrogels are also envisioned to be used as a GF delivery 
matrix, the release profile of PDGF-BB was assessed under static and EMF conditions.   
The release profile of PDGF was chosen because it is one of the most interesting factors present 
in PL. This GF presents mitogenic and chemotactic effects which is of utmost importance for the 
recruitment of progenitor cells to the defects and for the stimulation of their proliferation aiming 
regenerative medicine approaches[17]. As expected, in the conditions with HAse solution, the 
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release occurs faster and it relates to the profile of degradation. Also, under magnetic stimulation 
the PDGF-BB release is apparently higher than in non-EMF conditions.  This is in accordance to 
the work by Barbucci et all who showed the release of Doxorubicin incorporated in nanocellulose 
hydrogels was faster in the formulations under magnetic stimulation in hydrogels where the MNPs 
were physically incorporated in the matrix [30].  
The modulation and sustained release of bioactive molecules such as GF available in PL, is one of 
the most investigated parameters for tissue regeneration. The system herein presented is therefore 
expected to allow the adjustment of the release accordingly with the needs of the applications, thus 
fitting the complex requirements of the regenerative process. In fact as hypothesized GFs as PDFGF 
establish linkages with matrix of GAG, and the growth factor release depend on the degradation 
rate of the polymer. Accordingly with Zavan and colleagues the GF interacts with GAGs and the 
release of these molecules it is just driven by the degradation of the material. Other transport 
phenomena such as the diffusion process within the polymeric matrix and in the aqueous solution 
did not affect the release rate. Thus it was proven in this case that the EMF could impact the 
release of bio-molecules[38].  
Envisioning a therapeutic application of this versatile system, we proposed the biological 
assessment of the developed magnetic responsive 3D matrix having the tendon-to-bone interface 
as a potential target. Indeed, tendon-to-bone are roughly defined as an interconnection between 
two completely different tissues. Ideally, tissue engineering strategies should focus in replicating 
their complex cellular and biochemical composition reflecting the gradient of cells, biomolecules 
and ECM structural cues  Therefore, met-CS200 MAGPL hydrogels hydrogel were designed as a two 
unit system, a “tendon” unit and a “bone” unit in a single and finally co-culture system, homing in 
one side, cells that would potentially promote the regeneration of new tendon, hTDCs, and in the 
other side, cells with potential for bone regeneration.  
Human TDCs were chosen to be encapsulated in the tendon unit once they constitute a 
heterogeneous population of tendon resident cells which include mesenchymal stem cells known 
to mediate the reparative process after tendon injury[39]. For the bone unit hASCs pre 
differentiated into osteoblast like cells (pre-Ost) were chosen due to their recognized potential to 
differentiate into osteoblast like cells using standard differentiation protocols [40]. Moreover, hASCs 
were already proven to have the capacity for in vivo bone formation [41]. These units were produced 
and assessed as single units, and thus laden with hTDCs (tendon units) or with pre-Ost (bone units) 
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and as co-culture units with co-cultures of hTDCs and pre-Ost cells combining a tendon unit and a 
bone unit in a physical bond.   
The biological performance of this system for interfacial strategies was firstly evaluated as single 
units. Herein, the proliferation and metabolic activity of tendon and bone units under EMF showed 
values similar to the ones obtained with non-magnetic stimulation conditions. This is an expected 
result, since magnetic forces do not negatively influence biological processes of the cells and is in 
line with other investigations showing that cells hTDCs seeded onto a magnetic constructs of starch 
poly-ε-caprolactone (SPCL) under EMF do not evidenced changes in metabolic activity and 
proliferation [10]. Contrarily the cell morphology and deposition of proteins related to an ECM in 
the single hydrogels units was influenced by cellular location on the hydrogel, at the surface or in 
the inner sections, but also by the type of cells and EMF stimulation. 
Therefore, in the absence of EMF, the deposition of a tissue-like layer with spread cells enriched 
with ECM proteins was observed on the surface of the hydrogel. Inside the hydrogel, cells were 
rounded. In the core, cells   maintained the viability, with a reduced deposition of ECM.  Under 
magnetic stimulation cells remained with a rounded shape during the entire experiment being pre-
Ost cells organized in clusters of cells visualized 21 days after the encapsulation. The deposition 
of matrix proteins, including tenascin-C and Osteopontin was apparently denser in the core of the 
hydrogel when compared to hydrogels cultured in non EMF conditions.  
This results suggests that this versatile system can be used as a reservatory of cells with the 
capacity to adhere, proliferate and synthetize matrix in non-EMF conditions. Since the colonization 
without EMF increases with the time in culture, cells seem to be able to identify adhesion points in 
the matrix of the hydrogel to adhere and proliferate, principally at the surface. In fact Lamer and 
colleagues revealed that the adhesion of cells to the matrix needs time to maturate. In the case of 
EMF stimulation the adhesion locals are in “constant movement” due to the matrix destabilization 
as demonstrated in this work, and thus cells probably do not have time to maturate the adhesion 
to the surface and thus remained rounded [42]. 
Moreover as shown in this work, the presence of magnetic field impact the properties of the system, 
increasing its permeability which consequently improves the solutes diffusion and consequently 
the availability of nutrients and oxygen within the hydrogel. With this more “suitable” environment, 
cells were more prone to colonize and deposit matrix within the hydrogel core, forming the clusters 
of cells observed in the case in the case of pre-Ost.  Interesting is the fact that EMF seems to 
stimulate the deposition of TNC by hTDCs and OPN by pre-Ost within the hydrogel.  
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Indeed this modulation of ECM synthesis within the core of the hydrogel can also be related with 
the activation of mechanotransduction pathways through the magnetic actuation in the cells[9]. 
Once tendon and bone are mechanically responsive tissues, EMF may induce local deformations 
in the cells by itself or through the vibration of the met-CS MNPs present in the matrix, and activate 
multiple intracellular processes namely expression of specific genes etc[9].  This hypothesis was 
confirmed by the quantification of gene expression, which suggest that the expression of specific 
genes related with tendon (tenascin-C) and osteogenesis (Osteopontin) tended to be enhanced 
after 21 days in the presence of magnetic field in the respective single unit. In fact, Gonçalves et 
al demonstrated that EMF led to an increase in the expression of tendon related genes under 
magnetic stimulation[11]. Also it was demonstrated that the stimulation with pulsed 
electromagnetic field led to an increase in deposition of bone ECM related proteins as well as 
calcium deposits[43].  
Thus,  considering the results obtained, the cell laden hydrogel matrices where produced as a co-
culture hydrogel composed by a tendon unit and a bone unit to investigate the applicability of this 
versatile systems for tendon-to bone interface. As demonstrated for the single units, the metabolic 
activity of the co-culture systems was not affected by the magnetic stimulation. These results 
confirm that the produced hydrogel is suitable for encapsulating different types of cells and for 
further application in co-culture systems. Moreover contrary to single units in the developed co-
culture systems it is clear the communication and interplay between the hTDCs and hASC in which 
after 21 days, both type of cells were spreaded at the surface of the hydrogel independently of the 
magnetic stimulation. In fact, cells produced deposits of ECM related markers of bone and tendon 
(OPN, TEN) after 21 days in culture. Once more, in the studied conditions both cell types displayed 
a round morphology during the entire experiment within the hydrogel.  Moreover the deposition of 
bone and tendon related proteins was more evident in the bone and tendon zones, respectively of 
the co-culture system, which favors a “gradient” of matrix deposition As presented in the single 
units, the deposition of ECM related matrix seems to be higher inside of the hydrogel in EMF. This 
apparent proliferative and protein expression effect verified by immunolabeling assays is probably 
associated to the paracrine communication established between hTDCs and pre-Ost. Some reports 
demonstrated that cells secrete trophic factors that may stimulate tendon and bone ECM 
production and tissue remodeling[44]. Both type of cells likely produce a variety of cues, like release 
of cytokines that may have a crucial contribution for tissue maintenance and tissue regeneration 
[45], [46].  
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Nevertheless the interactions between these two type of cells in terms of paracrine signaling and 
extracellular matrix cues and how these cells influence each other behavior remains to be 
elucidated and should be deeply investigated in future studies. 
The analysis to the expression of tenogenesis or osteogenesis-related genes from the cells present 
in the “bone”, “tendon” or interface regions, revealed that the expression of tendon and bone 
related genes was apparently higher after 21 days in the correspondent unit of the hydrogel in non-
magnetic conditions following the gradient of expression as also demonstrated by 
immunofluorescence. Under magnetic stimulation the gene expression was maintained constant 
over time without the formation of a clear gene expression of tendon-bone gradient.  
Overall, the magnetic field has an impact in the modulation of the properties of the met-CS200 MAGPL 
hydrogels including the profile of swelling, degradation and release of biomolecules. Moreover in 
single hydrogel constructs, the EMF stimulate the expression of DCN and OPN in hTDCs and pre-
Ost, respectively with the time in culture, while without EMF the cells were able to colonize and 
produce matrix. In the co-cultre system, the cells were able to colonize and produce matrix 
independently of the EMF stimulation and the gene expression seems to be stabilized and 
maintained along the time and independently of the type of cells. Again these results may be due 
to the interactions established between such different cells as hTDCs and pre-Ost. Moreover, the 
mechanisms involved in the overexpression and upregulation of genes in a co-culture system may 
be associated to multiple processes the cells respond to, and to the complex stimulatory 
environment provided by EMF (mechanical), PL (biochemical), met-CS matrix (topographical) from 
our systems. 
 
3.6 Conlusions 
The produced magnetic hydrogel was demonstrated to be multifunctional, enabling the possibility 
of controlling several intrinsic properties of the system, including degradation and swelling through 
the use of EMF. Besides, the release of GF from the construct could also be tuned through the use 
of this stimulation. Moreover, the developed system can be used as a cell carrier for different types 
of cells, thus demonstrating its applicability envisioning different applications in the field of TE. In 
fact, this versatile magnetic hydrogel was demonstrated to support the colonization of human 
tendon cells and pre-osteoblasts, proving its potential for the use in tissue interfaces, particularly 
tendon-to-bone 
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4. CONCLUSIONS AND FINAL REMARKS 
The main goal of this work was to develop a versatile photopolimerizable hydrogel based on a 
matrix of chondroitin sulfate functionalized with methacrylated groups enriched with platelet lysate 
that could be remotely controlled or further manipulated ex vivo under the actuation of an external 
magnetic field. Herein this system was proposed to meet a major challenge for tissue regeneration 
which is the possibility to tune the intrinsic properties of a construct to the needs of tissue 
microenvironment and to the complex process of regeneration.  
Based on that, a magnetic met-CS hydrogel enriched with platelet lysate incorporating met-CS 
MNPs within the matrix was successfully produced. In this system we observed that properties as 
the swelling profile orthe rate of degradation could be externally manipulated by the application of 
ECM. Moreover the sustained release of growth factors (GFs) such as PDGF-BB from the PL 
confirms the potential of using the developed hydrogel as a GF delivery system for tissue 
regeneration strategies. Indeed, EMF was shown to increase the rate of PDGF-BB released from 
the hydrogels and likely improve the solutes diffusion and consequently the availability of nutrients 
and oxygen within the hydrogel. However it is not clear if this effect is due to the activation of met 
CS MNPs incorporated within the hydrogel through the stimulation of EMF or if it is just the 
presence of the magnetic field by itself. Thus, it could be important to assess the profile of GF 
release just with the use of the hydrogel without met-CS MNPs. 
Moreover the in vitro studies performed to assess the impact of this versatile system envisioning 
tendon-to-bone interfaces reveled that hTDCs and pre-Ost cultured alone in single hydrogel units 
or in co-culture in a hydrogel composed of two units were able to colonize and produce matrix thus 
forming tissue-like structures. The application of EMF in this system stimulated the genetic 
expression of DCN in hTDCs with the time in culture. Once the system permit the cell colonization 
and production of specific ECM proteins synthesized by different type of cells especially at later 
time points and the EMF stimulation increased the genetic expression of tendon genes, it could be 
interesting to assess the possible impact of alternating the application of EMF or just keep the 
actuation of the EMF for shorter periods of time. In fact this type of short EMF application in already 
applied in physiatrist patients with problems in musculoskeletal tissues, where a pulsed 
electromagnetic field is commonly used to bridge a non- or delayed bone fracture. 
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Neverthess, this system reveled to be a versatile construct that can fit their use for diverse areas 
of tissue regeneration including tissue interfaces like tendon-to-bone interface. In the co-culture 
system the two type of cells were able to proliferate and synthetize matrix in both conditions but 
the values of gene expression were maintained constant during the experience. In this particular 
case of tendon-to-bone interface it is important to perform further investigations in order to 
understand the interactions between these two types of cells in terms of paracrine signaling and 
extracellular matrix cues and how these cells influence each other and to understand the possible 
impact of EMF in native enthesis. To our knowledge the impact of EMF for tendon-to-bone interface 
has not been properly assessed and further studies on mechanosensing and mechanotranslation 
mechanisms of cells in response to EMF would greatly benefit the interfacial strategies towards 
interface tissue regeneration. Moreover this system can offer a possibility of being injectable directly 
into a defect and further polymerized, thus being and additional advantage using minimally invasive 
procedure. Once this system possess  magnetic responsiveness, hydrogel may be used as 
magnetic building blocks in order to create 3D structures with increased complexity towards 
recreating or producing tissue-like structures for biomedical applications.   
Overall, the results reported in this Thesis, show that this magnetic responsive hydrogel represents 
a valuable resource for tissue engineering, not only as a controllable source of GF from PL in which 
the properties of the system could be externally modulated through EMF stimulation but also as a 
cell carrier. 
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Synthesis and characterization of methacrylated chondroitin sulfate  
CS was successfully modified through a reaction with methacrylic anhydride (MA) (Figure 3.1), 
originating methacrylic groups in its backbone. The efficiency of the modification process was 
evaluated by NMR spectroscopy (Figure A.1). The degree of substitution which corresponds to the 
methacryloyl groups per disaccharide repeat unit, was calculated from the NMR spectrum as the 
ratio between the relative peak integrations of the methacrylate protons (δ 5.77 – 6.20 ppm) and 
the methyl protons of CS (δ 2.05 ppm). The degree of substitution of methacrylated CS polymer 
was was 24%. 
 
Figure A.1: 1H NMR spectrum of methacrylated chondroitin sulfate (met-CS) 
 
 
 
 
 
 
 
 
 
 
 
ANNEX 1 
